Drug1_ID,Drug1_Name,Drug2_ID,Drug2_Name,Prediction_Score,Predicted_Type_Index,Predicted_Type_Name,Interaction_Translation,True_Type_Index,True_Type_Name,Match
DB00762,Irinotecan,DB08896,Regorafenib,0.4803900718688965,47,Type_47,The metabolism of Regorafenib can be decreased when combined with Irinotecan.,77,Type_77,No
DB00191,Phentermine,DB01142,Doxepin,0.42233020067214966,76,Type_76,Phentermine may decrease the sedative activities of Doxepin.,76,Type_76,Yes
DB00679,Thioridazine,DB09242,Moxonidine,0.38952746987342834,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Moxonidine.,49,Type_49,Yes
DB00541,Vincristine,DB13179,Troleandomycin,0.4993850886821747,73,Type_73,The serum concentration of Troleandomycin can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00371,Meprobamate,DB09280,Lumacaftor,0.46178555488586426,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Meprobamate.,75,Type_75,Yes
DB00334,Olanzapine,DB01416,Cefpodoxime,0.3838789761066437,75,Type_75,The serum concentration of Cefpodoxime can be decreased when it is combined with Olanzapine.,67,Type_67,No
DB01018,Guanfacine,DB01171,Moclobemide,0.4840031564235687,49,Type_49,The risk or severity of adverse effects can be increased when Guanfacine is combined with Moclobemide.,47,Type_47,No
DB00651,Dyphylline,DB01032,Probenecid,0.49464496970176697,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Dyphylline.,73,Type_73,Yes
DB00696,Ergotamine,DB04876,Vildagliptin,0.41538792848587036,49,Type_49,The risk or severity of adverse effects can be increased when Ergotamine is combined with Vildagliptin.,73,Type_73,No
DB00255,Diethylstilbestrol,DB09119,Eslicarbazepine acetate,0.47335803508758545,47,Type_47,The metabolism of Eslicarbazepine acetate can be decreased when combined with Diethylstilbestrol.,75,Type_75,No
DB00455,Loratadine,DB06335,Saxagliptin,0.4838241636753082,73,Type_73,The serum concentration of Saxagliptin can be increased when it is combined with Loratadine.,75,Type_75,No
DB00404,Alprazolam,DB00584,Enalapril,0.28952986001968384,73,Type_73,The serum concentration of Enalapril can be increased when it is combined with Alprazolam.,73,Type_73,Yes
DB04946,Iloperidone,DB09039,Eliglustat,0.4899516999721527,20,Type_20,Iloperidone may increase the QTc-prolonging activities of Eliglustat.,47,Type_47,No
DB00726,Trimipramine,DB05265,Ecabet,0.4659937918186188,73,Type_73,The serum concentration of Ecabet can be increased when it is combined with Trimipramine.,73,Type_73,Yes
DB01251,Gliquidone,DB01590,Everolimus,0.3625134527683258,70,Type_70,The therapeutic efficacy of Everolimus can be decreased when used in combination with Gliquidone.,70,Type_70,Yes
DB00361,Vinorelbine,DB00951,Isoniazid,0.402056485414505,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Vinorelbine.,47,Type_47,Yes
DB01263,Posaconazole,DB06203,Alogliptin,0.48231440782546997,73,Type_73,The serum concentration of Alogliptin can be increased when it is combined with Posaconazole.,47,Type_47,No
DB00615,Rifabutin,DB06176,Romidepsin,0.4853314161300659,75,Type_75,The serum concentration of Romidepsin can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB01220,Rifaximin,DB01253,Ergometrine,0.4290081262588501,73,Type_73,The serum concentration of Ergometrine can be increased when it is combined with Rifaximin.,73,Type_73,Yes
DB00182,Amphetamine,DB00501,Cimetidine,0.4568818211555481,47,Type_47,The metabolism of Cimetidine can be decreased when combined with Amphetamine.,47,Type_47,Yes
DB00188,Bortezomib,DB00637,Astemizole,0.33724507689476013,20,Type_20,Bortezomib may increase the QTc-prolonging activities of Astemizole.,47,Type_47,No
DB00420,Promazine,DB00575,Clonidine,0.44378209114074707,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Clonidine.,47,Type_47,No
DB00188,Bortezomib,DB00321,Amitriptyline,0.4740275740623474,20,Type_20,Bortezomib may increase the QTc-prolonging activities of Amitriptyline.,47,Type_47,No
DB01153,Sertaconazole,DB01268,Sunitinib,0.4493236243724823,73,Type_73,The serum concentration of Sunitinib can be increased when it is combined with Sertaconazole.,47,Type_47,No
DB00335,Atenolol,DB01403,Methotrimeprazine,0.31085118651390076,47,Type_47,The metabolism of Methotrimeprazine can be decreased when combined with Atenolol.,60,Type_60,No
DB00243,Ranolazine,DB00528,Lercanidipine,0.4642869830131531,73,Type_73,The serum concentration of Lercanidipine can be increased when it is combined with Ranolazine.,47,Type_47,No
DB00313,Valproic acid,DB09053,Ibrutinib,0.418425053358078,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Valproic acid.,73,Type_73,Yes
DB00490,Buspirone,DB01233,Metoclopramide,0.45725348591804504,64,Type_64,Buspirone may increase the serotonergic activities of Metoclopramide.,49,Type_49,No
DB00178,Ramipril,DB00390,Digoxin,0.35750651359558105,73,Type_73,The serum concentration of Digoxin can be increased when it is combined with Ramipril.,73,Type_73,Yes
DB06605,Apixaban,DB06717,Fosaprepitant,0.31945401430130005,73,Type_73,The serum concentration of Fosaprepitant can be increased when it is combined with Apixaban.,73,Type_73,Yes
DB00333,Methadone,DB00980,Ramelteon,0.3897899091243744,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Ramelteon.,49,Type_49,Yes
DB06335,Saxagliptin,DB09054,Idelalisib,0.4767022132873535,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Saxagliptin.,73,Type_73,No
DB00315,Zolmitriptan,DB08881,Vemurafenib,0.40757909417152405,33,Type_33,The risk or severity of QTc prolongation can be increased when Zolmitriptan is combined with Vemurafenib.,73,Type_73,No
DB00641,Simvastatin,DB01029,Irbesartan,0.3580513894557953,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Simvastatin.,47,Type_47,Yes
DB00622,Nicardipine,DB01624,Zuclopenthixol,0.4888342022895813,20,Type_20,Nicardipine may increase the QTc-prolonging activities of Zuclopenthixol.,20,Type_20,Yes
DB01197,Captopril,DB09026,Aliskiren,0.47893819212913513,49,Type_49,The risk or severity of adverse effects can be increased when Captopril is combined with Aliskiren.,68,Type_68,No
DB01242,Clomipramine,DB09242,Moxonidine,0.439333438873291,70,Type_70,The therapeutic efficacy of Moxonidine can be decreased when used in combination with Clomipramine.,70,Type_70,Yes
DB00238,Nevirapine,DB01223,Aminophylline,0.3788515627384186,4,Type_4,The metabolism of Aminophylline can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00215,Citalopram,DB06708,Lumefantrine,0.4551653265953064,20,Type_20,Citalopram may increase the QTc-prolonging activities of Lumefantrine.,47,Type_47,No
DB00417,Phenoxymethylpenicillin,DB13783,Acemetacin,0.3733757734298706,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Phenoxymethylpenicillin.,72,Type_72,No
DB00521,Carteolol,DB01118,Amiodarone,0.44555148482322693,54,Type_54,Carteolol may increase the bradycardic activities of Amiodarone.,54,Type_54,Yes
DB00185,Cevimeline,DB00843,Donepezil,0.3125832676887512,75,Type_75,The serum concentration of Donepezil can be decreased when it is combined with Cevimeline.,49,Type_49,No
DB00614,Furazolidone,DB01171,Moclobemide,0.4323519170284271,49,Type_49,The risk or severity of adverse effects can be increased when Furazolidone is combined with Moclobemide.,49,Type_49,Yes
DB00619,Imatinib,DB01098,Rosuvastatin,0.4808599054813385,47,Type_47,The metabolism of Rosuvastatin can be decreased when combined with Imatinib.,47,Type_47,Yes
DB00396,Progesterone,DB00569,Fondaparinux,0.4270540475845337,75,Type_75,The serum concentration of Fondaparinux can be decreased when it is combined with Progesterone.,70,Type_70,No
DB01074,Perhexiline,DB01095,Fluvastatin,0.46300050616264343,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Perhexiline.,49,Type_49,No
DB00526,Oxaliplatin,DB08880,Teriflunomide,0.3631505072116852,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Oxaliplatin.,75,Type_75,Yes
DB00451,Levothyroxine,DB08918,Levomilnacipran,0.4389066994190216,70,Type_70,The therapeutic efficacy of Levomilnacipran can be decreased when used in combination with Levothyroxine.,70,Type_70,Yes
DB00175,Pravastatin,DB00448,Lansoprazole,0.4093947112560272,73,Type_73,The serum concentration of Lansoprazole can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00224,Indinavir,DB01357,Mestranol,0.3807452321052551,47,Type_47,The metabolism of Mestranol can be decreased when combined with Indinavir.,75,Type_75,No
DB00700,Eplerenone,DB01242,Clomipramine,0.41841182112693787,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Clomipramine.,49,Type_49,Yes
DB00568,Cinnarizine,DB00997,Doxorubicin,0.49698272347450256,73,Type_73,The serum concentration of Doxorubicin can be increased when it is combined with Cinnarizine.,47,Type_47,No
DB01609,Deferasirox,DB04552,Niflumic acid,0.44659456610679626,49,Type_49,The risk or severity of adverse effects can be increased when Deferasirox is combined with Niflumic acid.,49,Type_49,Yes
DB00875,Flupentixol,DB01320,Fosphenytoin,0.33660057187080383,49,Type_49,The risk or severity of adverse effects can be increased when Flupentixol is combined with Fosphenytoin.,49,Type_49,Yes
DB00321,Amitriptyline,DB06697,Artemether,0.4504290223121643,47,Type_47,The metabolism of Artemether can be decreased when combined with Amitriptyline.,20,Type_20,No
DB00489,Sotalol,DB01072,Atazanavir,0.4540463387966156,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Sotalol.,20,Type_20,No
DB00393,Nimodipine,DB00571,Propranolol,0.4981444478034973,49,Type_49,The risk or severity of adverse effects can be increased when Nimodipine is combined with Propranolol.,49,Type_49,Yes
DB00615,Rifabutin,DB09227,Barnidipine,0.32454490661621094,4,Type_4,The metabolism of Barnidipine can be increased when combined with Rifabutin.,75,Type_75,No
DB00091,Cyclosporine,DB00474,Methohexital,0.46503746509552,47,Type_47,The metabolism of Methohexital can be decreased when combined with Cyclosporine.,4,Type_4,No
DB00458,Imipramine,DB06292,Dapagliflozin,0.41091030836105347,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Imipramine.,49,Type_49,No
DB00254,Doxycycline,DB00948,Mezlocillin,0.2905817925930023,70,Type_70,The therapeutic efficacy of Mezlocillin can be decreased when used in combination with Doxycycline.,70,Type_70,Yes
DB01397,Magnesium salicylate,DB01580,Oxprenolol,0.35966062545776367,70,Type_70,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Magnesium salicylate.,37,Type_37,No
DB00521,Carteolol,DB03128,Acetylcholine,0.4448844790458679,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Acetylcholine.,49,Type_49,Yes
DB00188,Bortezomib,DB05294,Vandetanib,0.4336971342563629,20,Type_20,Bortezomib may increase the QTc-prolonging activities of Vandetanib.,20,Type_20,Yes
DB00277,Theophylline,DB01095,Fluvastatin,0.44010382890701294,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Theophylline.,47,Type_47,No
DB09065,Cobicistat,DB09570,Ixazomib,0.48590484261512756,73,Type_73,The serum concentration of Ixazomib can be increased when it is combined with Cobicistat.,73,Type_73,Yes
DB00588,Fluticasone propionate,DB01017,Minocycline,0.4896775782108307,49,Type_49,The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Minocycline.,16,Type_16,No
DB00268,Ropinirole,DB00696,Ergotamine,0.36428430676460266,19,Type_19,Ropinirole may increase the vasoconstricting activities of Ergotamine.,47,Type_47,No
DB00215,Citalopram,DB01623,Thiothixene,0.3761482834815979,20,Type_20,Citalopram may increase the QTc-prolonging activities of Thiothixene.,20,Type_20,Yes
DB00220,Nelfinavir,DB00615,Rifabutin,0.32533296942710876,75,Type_75,The serum concentration of Rifabutin can be decreased when it is combined with Nelfinavir.,77,Type_77,No
DB00861,Diflunisal,DB00975,Dipyridamole,0.4914630055427551,49,Type_49,The risk or severity of adverse effects can be increased when Diflunisal is combined with Dipyridamole.,49,Type_49,Yes
DB00726,Trimipramine,DB06216,Asenapine,0.4840426445007324,20,Type_20,Trimipramine may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB00829,Diazepam,DB06148,Mianserin,0.455835223197937,70,Type_70,The therapeutic efficacy of Mianserin can be decreased when used in combination with Diazepam.,70,Type_70,Yes
DB00564,Carbamazepine,DB01319,Fosamprenavir,0.4622901380062103,4,Type_4,The metabolism of Fosamprenavir can be increased when combined with Carbamazepine.,4,Type_4,Yes
DB00243,Ranolazine,DB00757,Dolasetron,0.457979291677475,47,Type_47,The metabolism of Dolasetron can be decreased when combined with Ranolazine.,20,Type_20,No
DB00734,Risperidone,DB00796,Candesartan cilexetil,0.4033242166042328,73,Type_73,The serum concentration of Candesartan cilexetil can be increased when it is combined with Risperidone.,60,Type_60,No
DB00575,Clonidine,DB00857,Terbinafine,0.49949148297309875,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Clonidine.,47,Type_47,Yes
DB00296,Ropivacaine,DB00907,Cocaine,0.42535361647605896,47,Type_47,The metabolism of Cocaine can be decreased when combined with Ropivacaine.,47,Type_47,Yes
DB00215,Citalopram,DB00521,Carteolol,0.489381343126297,47,Type_47,The metabolism of Carteolol can be decreased when combined with Citalopram.,47,Type_47,Yes
DB01097,Leflunomide,DB08860,Pitavastatin,0.3847010135650635,73,Type_73,The serum concentration of Pitavastatin can be increased when it is combined with Leflunomide.,47,Type_47,No
DB00735,Naftifine,DB01268,Sunitinib,0.4214975833892822,73,Type_73,The serum concentration of Sunitinib can be increased when it is combined with Naftifine.,47,Type_47,No
DB01224,Quetiapine,DB01259,Lapatinib,0.42910826206207275,47,Type_47,The metabolism of Lapatinib can be decreased when combined with Quetiapine.,20,Type_20,No
DB00790,Perindopril,DB01592,Iron,0.44532570242881775,49,Type_49,The risk or severity of adverse effects can be increased when Perindopril is combined with Iron.,49,Type_49,Yes
DB00568,Cinnarizine,DB08880,Teriflunomide,0.409292995929718,70,Type_70,The therapeutic efficacy of Teriflunomide can be decreased when used in combination with Cinnarizine.,75,Type_75,No
DB00313,Valproic acid,DB01580,Oxprenolol,0.3240407109260559,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Oxprenolol.,49,Type_49,Yes
DB00213,Pantoprazole,DB00541,Vincristine,0.49660518765449524,47,Type_47,The metabolism of Vincristine can be decreased when combined with Pantoprazole.,73,Type_73,No
DB00091,Cyclosporine,DB06626,Axitinib,0.44368648529052734,47,Type_47,The metabolism of Axitinib can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00433,Prochlorperazine,DB08881,Vemurafenib,0.4660683274269104,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Prochlorperazine.,33,Type_33,No
DB00285,Venlafaxine,DB01100,Pimozide,0.44213104248046875,20,Type_20,Venlafaxine may increase the QTc-prolonging activities of Pimozide.,73,Type_73,No
DB06210,Eltrombopag,DB11613,Velpatasvir,0.48241809010505676,47,Type_47,The metabolism of Velpatasvir can be decreased when combined with Eltrombopag.,73,Type_73,No
DB00255,Diethylstilbestrol,DB00555,Lamotrigine,0.4229879081249237,70,Type_70,The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Diethylstilbestrol.,75,Type_75,No
DB00238,Nevirapine,DB01426,Ajmaline,0.3685155212879181,47,Type_47,The metabolism of Ajmaline can be decreased when combined with Nevirapine.,47,Type_47,Yes
DB00193,Tramadol,DB08893,Mirabegron,0.4034745991230011,64,Type_64,Tramadol may increase the serotonergic activities of Mirabegron.,70,Type_70,No
DB01238,Aripiprazole,DB01242,Clomipramine,0.36665478348731995,49,Type_49,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Clomipramine.,73,Type_73,No
DB00205,Pyrimethamine,DB00531,Cyclophosphamide,0.4239148795604706,47,Type_47,The metabolism of Cyclophosphamide can be decreased when combined with Pyrimethamine.,47,Type_47,Yes
DB00227,Lovastatin,DB06708,Lumefantrine,0.45412299036979675,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB08873,Boceprevir,DB09280,Lumacaftor,0.4769924283027649,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Boceprevir.,75,Type_75,Yes
DB01182,Propafenone,DB01238,Aripiprazole,0.4664185345172882,73,Type_73,The serum concentration of Aripiprazole can be increased when it is combined with Propafenone.,20,Type_20,No
DB00334,Olanzapine,DB00818,Propofol,0.495217502117157,20,Type_20,Olanzapine may increase the QTc-prolonging activities of Propofol.,49,Type_49,No
DB00206,Reserpine,DB09280,Lumacaftor,0.4279833137989044,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Reserpine.,75,Type_75,Yes
DB00220,Nelfinavir,DB01319,Fosamprenavir,0.46701106429100037,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Nelfinavir.,47,Type_47,Yes
DB00248,Cabergoline,DB00390,Digoxin,0.32621070742607117,25,Type_25,Cabergoline may increase the atrioventricular blocking (AV block) activities of Digoxin.,58,Type_58,No
DB01218,Halofantrine,DB09241,Methylene blue,0.3302984833717346,47,Type_47,The metabolism of Methylene blue can be decreased when combined with Halofantrine.,73,Type_73,No
DB00932,Tipranavir,DB06203,Alogliptin,0.4190502464771271,70,Type_70,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Tipranavir.,75,Type_75,No
DB00204,Dofetilide,DB00555,Lamotrigine,0.4801100194454193,82,Type_82,Dofetilide may increase the arrhythmogenic activities of Lamotrigine.,73,Type_73,No
DB00503,Ritonavir,DB01261,Sitagliptin,0.41078490018844604,47,Type_47,The metabolism of Sitagliptin can be decreased when combined with Ritonavir.,70,Type_70,No
DB00175,Pravastatin,DB01241,Gemfibrozil,0.45393869280815125,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Pravastatin.,48,Type_48,No
DB00705,Delavirdine,DB00898,Ethanol,0.4537239074707031,47,Type_47,The metabolism of Ethanol can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00373,Timolol,DB01236,Sevoflurane,0.423560231924057,47,Type_47,The metabolism of Sevoflurane can be decreased when combined with Timolol.,49,Type_49,No
DB00246,Ziprasidone,DB00946,Phenprocoumon,0.41061779856681824,47,Type_47,The metabolism of Phenprocoumon can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB01154,Thiamylal,DB09289,Tianeptine,0.2704486548900604,47,Type_47,The metabolism of Tianeptine can be decreased when combined with Thiamylal.,4,Type_4,No
DB00257,Clotrimazole,DB00312,Pentobarbital,0.4025762379169464,47,Type_47,The metabolism of Pentobarbital can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00273,Topiramate,DB09118,Stiripentol,0.49079543352127075,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Topiramate.,49,Type_49,No
DB00503,Ritonavir,DB09039,Eliglustat,0.3534206449985504,73,Type_73,The serum concentration of Eliglustat can be increased when it is combined with Ritonavir.,73,Type_73,Yes
DB00193,Tramadol,DB01104,Sertraline,0.49843114614486694,27,Type_27,Tramadol may increase the neuroexcitatory activities of Sertraline.,27,Type_27,Yes
DB00182,Amphetamine,DB00924,Cyclobenzaprine,0.49668991565704346,23,Type_23,Amphetamine may increase the stimulatory activities of Cyclobenzaprine.,64,Type_64,No
DB00182,Amphetamine,DB00918,Almotriptan,0.4976554214954376,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Almotriptan.,73,Type_73,No
DB00682,Warfarin,DB09079,Nintedanib,0.48455139994621277,49,Type_49,The risk or severity of adverse effects can be increased when Warfarin is combined with Nintedanib.,49,Type_49,Yes
DB00393,Nimodipine,DB01264,Darunavir,0.45421671867370605,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Nimodipine.,73,Type_73,Yes
DB00422,Methylphenidate,DB00496,Darifenacin,0.49860474467277527,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Darifenacin.,47,Type_47,No
DB00625,Efavirenz,DB01076,Atorvastatin,0.3803768754005432,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Efavirenz.,75,Type_75,No
DB01197,Captopril,DB01592,Iron,0.48159557580947876,75,Type_75,The serum concentration of Iron can be decreased when it is combined with Captopril.,49,Type_49,No
DB00187,Esmolol,DB00477,Chlorpromazine,0.4801151156425476,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Chlorpromazine.,60,Type_60,No
DB00592,Piperazine,DB00715,Paroxetine,0.4574154019355774,47,Type_47,The metabolism of Paroxetine can be decreased when combined with Piperazine.,47,Type_47,Yes
DB00503,Ritonavir,DB00637,Astemizole,0.45133644342422485,47,Type_47,The metabolism of Astemizole can be decreased when combined with Ritonavir.,47,Type_47,Yes
DB00243,Ranolazine,DB00656,Trazodone,0.4239474833011627,73,Type_73,The serum concentration of Trazodone can be increased when it is combined with Ranolazine.,47,Type_47,No
DB00614,Furazolidone,DB01037,Selegiline,0.3698229193687439,71,Type_71,Furazolidone may increase the hypertensive activities of Selegiline.,71,Type_71,Yes
DB00338,Omeprazole,DB00541,Vincristine,0.48370635509490967,47,Type_47,The metabolism of Vincristine can be decreased when combined with Omeprazole.,73,Type_73,No
DB01037,Selegiline,DB01626,Pargyline,0.4263564646244049,60,Type_60,Selegiline may increase the hypotensive activities of Pargyline.,60,Type_60,Yes
DB01264,Darunavir,DB01357,Mestranol,0.45394736528396606,75,Type_75,The serum concentration of Mestranol can be decreased when it is combined with Darunavir.,75,Type_75,Yes
DB00252,Phenytoin,DB01235,Levodopa,0.4387918710708618,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Levodopa.,70,Type_70,No
DB00179,Masoprocol,DB00796,Candesartan cilexetil,0.4828696846961975,37,Type_37,Masoprocol may decrease the antihypertensive activities of Candesartan cilexetil.,49,Type_49,No
DB00206,Reserpine,DB01078,Deslanoside,0.4685095250606537,25,Type_25,Reserpine may increase the atrioventricular blocking (AV block) activities of Deslanoside.,49,Type_49,No
DB00518,Albendazole,DB09280,Lumacaftor,0.46582654118537903,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Albendazole.,4,Type_4,No
DB00091,Cyclosporine,DB00163,Vitamin E,0.4404396414756775,49,Type_49,The risk or severity of adverse effects can be increased when Cyclosporine is combined with Vitamin E.,75,Type_75,No
DB00495,Zidovudine,DB01132,Pioglitazone,0.46838700771331787,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Zidovudine.,47,Type_47,Yes
DB08918,Levomilnacipran,DB09280,Lumacaftor,0.4699109196662903,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Levomilnacipran.,73,Type_73,Yes
DB00678,Losartan,DB00696,Ergotamine,0.46033838391304016,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Ergotamine.,49,Type_49,Yes
DB00238,Nevirapine,DB00932,Tipranavir,0.3147284686565399,4,Type_4,The metabolism of Tipranavir can be increased when combined with Nevirapine.,4,Type_4,Yes
DB00338,Omeprazole,DB01238,Aripiprazole,0.4414334297180176,75,Type_75,The serum concentration of Aripiprazole can be decreased when it is combined with Omeprazole.,75,Type_75,Yes
DB01319,Fosamprenavir,DB04868,Nilotinib,0.49165692925453186,73,Type_73,The serum concentration of Nilotinib can be increased when it is combined with Fosamprenavir.,47,Type_47,No
DB00927,Famotidine,DB01072,Atazanavir,0.4029664695262909,20,Type_20,Famotidine may increase the QTc-prolonging activities of Atazanavir.,75,Type_75,No
DB00424,Hyoscyamine,DB01390,Sodium bicarbonate,0.3365892171859741,73,Type_73,The serum concentration of Sodium bicarbonate can be increased when it is combined with Hyoscyamine.,75,Type_75,No
DB00227,Lovastatin,DB08883,Perampanel,0.4012632966041565,47,Type_47,The metabolism of Perampanel can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00227,Lovastatin,DB09280,Lumacaftor,0.4504672884941101,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Lovastatin.,4,Type_4,No
DB00266,Dicoumarol,DB06701,Dexmethylphenidate,0.43661922216415405,73,Type_73,The serum concentration of Dexmethylphenidate can be increased when it is combined with Dicoumarol.,73,Type_73,Yes
DB01580,Oxprenolol,DB01623,Thiothixene,0.3502064049243927,49,Type_49,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Thiothixene.,49,Type_49,Yes
DB01026,Ketoconazole,DB01232,Saquinavir,0.4261433184146881,73,Type_73,The serum concentration of Saquinavir can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB00224,Indinavir,DB01098,Rosuvastatin,0.48990586400032043,73,Type_73,The serum concentration of Rosuvastatin can be increased when it is combined with Indinavir.,73,Type_73,Yes
DB00243,Ranolazine,DB01208,Sparfloxacin,0.45307159423828125,73,Type_73,The serum concentration of Sparfloxacin can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00503,Ritonavir,DB04876,Vildagliptin,0.45045650005340576,47,Type_47,The metabolism of Vildagliptin can be decreased when combined with Ritonavir.,70,Type_70,No
DB00999,Hydrochlorothiazide,DB01359,Penbutolol,0.49637261033058167,49,Type_49,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Penbutolol.,49,Type_49,Yes
DB01221,Ketamine,DB09280,Lumacaftor,0.43833550810813904,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Ketamine.,73,Type_73,No
DB00687,Fludrocortisone,DB01656,Roflumilast,0.45706555247306824,34,Type_34,Fludrocortisone may increase the immunosuppressive activities of Roflumilast.,34,Type_34,Yes
DB00641,Simvastatin,DB01076,Atorvastatin,0.40033435821533203,49,Type_49,The risk or severity of adverse effects can be increased when Simvastatin is combined with Atorvastatin.,49,Type_49,Yes
DB00320,Dihydroergotamine,DB00584,Enalapril,0.46680691838264465,47,Type_47,The metabolism of Enalapril can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00705,Delavirdine,DB09123,Dienogest,0.2861885726451874,75,Type_75,The serum concentration of Dienogest can be decreased when it is combined with Delavirdine.,47,Type_47,No
DB00542,Benazepril,DB08873,Boceprevir,0.4509127140045166,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Benazepril.,75,Type_75,No
DB04839,Cyproterone acetate,DB06203,Alogliptin,0.4075746536254883,75,Type_75,The serum concentration of Alogliptin can be decreased when it is combined with Cyproterone acetate.,70,Type_70,No
DB00613,Amodiaquine,DB01076,Atorvastatin,0.44264525175094604,47,Type_47,The metabolism of Atorvastatin can be decreased when combined with Amodiaquine.,73,Type_73,No
DB00440,Trimethoprim,DB08880,Teriflunomide,0.45963868498802185,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Trimethoprim.,47,Type_47,No
DB01071,Mequitazine,DB06708,Lumefantrine,0.47686952352523804,82,Type_82,Mequitazine may increase the arrhythmogenic activities of Lumefantrine.,47,Type_47,No
DB04876,Vildagliptin,DB09289,Tianeptine,0.34571465849876404,47,Type_47,The metabolism of Tianeptine can be decreased when combined with Vildagliptin.,73,Type_73,No
DB00188,Bortezomib,DB01320,Fosphenytoin,0.49303343892097473,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Bortezomib.,75,Type_75,No
DB01236,Sevoflurane,DB01267,Paliperidone,0.4657887816429138,20,Type_20,Sevoflurane may increase the QTc-prolonging activities of Paliperidone.,20,Type_20,Yes
DB00469,Tenoxicam,DB09280,Lumacaftor,0.4592595100402832,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Tenoxicam.,75,Type_75,Yes
DB01041,Thalidomide,DB01124,Tolbutamide,0.47035688161849976,70,Type_70,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Thalidomide.,47,Type_47,No
DB01026,Ketoconazole,DB09216,Tolfenamic acid,0.38171079754829407,47,Type_47,The metabolism of Tolfenamic acid can be decreased when combined with Ketoconazole.,49,Type_49,No
DB00802,Alfentanil,DB01246,Alimemazine,0.41352686285972595,49,Type_49,The risk or severity of adverse effects can be increased when Alfentanil is combined with Alimemazine.,60,Type_60,No
DB00608,Chloroquine,DB01622,Thioproperazine,0.3033123016357422,27,Type_27,Chloroquine may increase the neuroexcitatory activities of Thioproperazine.,73,Type_73,No
DB01182,Propafenone,DB09039,Eliglustat,0.40745773911476135,20,Type_20,Propafenone may increase the QTc-prolonging activities of Eliglustat.,73,Type_73,No
DB01154,Thiamylal,DB01223,Aminophylline,0.4581928253173828,75,Type_75,The serum concentration of Aminophylline can be decreased when it is combined with Thiamylal.,75,Type_75,Yes
DB01095,Fluvastatin,DB01110,Miconazole,0.4670283794403076,73,Type_73,The serum concentration of Miconazole can be increased when it is combined with Fluvastatin.,73,Type_73,Yes
DB00672,Chlorpropamide,DB01220,Rifaximin,0.342388778924942,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Chlorpropamide.,73,Type_73,Yes
DB00603,Medroxyprogesterone acetate,DB01072,Atazanavir,0.47788020968437195,75,Type_75,The serum concentration of Atazanavir can be decreased when it is combined with Medroxyprogesterone acetate.,73,Type_73,No
DB00297,Bupivacaine,DB00598,Labetalol,0.4960795044898987,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Labetalol.,73,Type_73,No
DB00213,Pantoprazole,DB01024,Mycophenolic acid,0.40305301547050476,47,Type_47,The metabolism of Mycophenolic acid can be decreased when combined with Pantoprazole.,75,Type_75,No
DB00812,Phenylbutazone,DB05812,Abiraterone,0.48884737491607666,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Phenylbutazone.,47,Type_47,No
DB00482,Celecoxib,DB01357,Mestranol,0.4461929500102997,47,Type_47,The metabolism of Mestranol can be decreased when combined with Celecoxib.,81,Type_81,No
DB00472,Fluoxetine,DB06589,Pazopanib,0.4723139703273773,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Fluoxetine.,73,Type_73,Yes
DB00252,Phenytoin,DB00277,Theophylline,0.4698883891105652,4,Type_4,The metabolism of Theophylline can be increased when combined with Phenytoin.,75,Type_75,No
DB01118,Amiodarone,DB01297,Practolol,0.4802285432815552,54,Type_54,Amiodarone may increase the bradycardic activities of Practolol.,54,Type_54,Yes
DB00091,Cyclosporine,DB04574,Estrone sulfate,0.4123770594596863,47,Type_47,The metabolism of Estrone sulfate can be decreased when combined with Cyclosporine.,47,Type_47,Yes
DB00215,Citalopram,DB04868,Nilotinib,0.47795259952545166,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00991,Oxaprozin,DB09280,Lumacaftor,0.49449247121810913,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Oxaprozin.,75,Type_75,Yes
DB01609,Deferasirox,DB08816,Ticagrelor,0.49691030383110046,75,Type_75,The serum concentration of Ticagrelor can be decreased when it is combined with Deferasirox.,75,Type_75,Yes
DB00182,Amphetamine,DB00656,Trazodone,0.4303867518901825,47,Type_47,The metabolism of Trazodone can be decreased when combined with Amphetamine.,64,Type_64,No
DB00188,Bortezomib,DB01403,Methotrimeprazine,0.36578717827796936,73,Type_73,The serum concentration of Methotrimeprazine can be increased when it is combined with Bortezomib.,47,Type_47,No
DB00461,Nabumetone,DB00710,Ibandronate,0.47699785232543945,49,Type_49,The risk or severity of adverse effects can be increased when Nabumetone is combined with Ibandronate.,49,Type_49,Yes
DB00252,Phenytoin,DB00396,Progesterone,0.43731027841567993,75,Type_75,The serum concentration of Progesterone can be decreased when it is combined with Phenytoin.,4,Type_4,No
DB00327,Hydromorphone,DB00496,Darifenacin,0.4432528614997864,49,Type_49,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Darifenacin.,47,Type_47,No
DB01395,Drospirenone,DB01601,Lopinavir,0.4521012604236603,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Drospirenone.,75,Type_75,No
DB00783,Estradiol,DB01223,Aminophylline,0.48782241344451904,75,Type_75,The serum concentration of Aminophylline can be decreased when it is combined with Estradiol.,73,Type_73,No
DB00582,Voriconazole,DB00653,Magnesium sulfate,0.49315041303634644,47,Type_47,The metabolism of Magnesium sulfate can be decreased when combined with Voriconazole.,49,Type_49,No
DB00627,Niacin,DB00679,Thioridazine,0.2986955940723419,73,Type_73,The serum concentration of Thioridazine can be increased when it is combined with Niacin.,73,Type_73,Yes
DB01045,Rifampicin,DB06717,Fosaprepitant,0.4756101965904236,75,Type_75,The serum concentration of Fosaprepitant can be decreased when it is combined with Rifampicin.,75,Type_75,Yes
DB01321,Josamycin,DB04743,Nimesulide,0.3425407111644745,49,Type_49,The risk or severity of adverse effects can be increased when Josamycin is combined with Nimesulide.,47,Type_47,No
DB01263,Posaconazole,DB04946,Iloperidone,0.44057130813598633,47,Type_47,The metabolism of Iloperidone can be decreased when combined with Posaconazole.,77,Type_77,No
DB00333,Methadone,DB09245,Toloxatone,0.3999807834625244,64,Type_64,Methadone may increase the serotonergic activities of Toloxatone.,49,Type_49,No
DB00554,Piroxicam,DB09280,Lumacaftor,0.46506550908088684,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Piroxicam.,73,Type_73,No
DB00487,Pefloxacin,DB00651,Dyphylline,0.3772796392440796,47,Type_47,The metabolism of Dyphylline can be decreased when combined with Pefloxacin.,47,Type_47,Yes
DB00390,Digoxin,DB00633,Dexmedetomidine,0.38835448026657104,25,Type_25,Digoxin may increase the atrioventricular blocking (AV block) activities of Dexmedetomidine.,54,Type_54,No
DB00489,Sotalol,DB01370,Aluminium,0.46036359667778015,82,Type_82,Sotalol may increase the arrhythmogenic activities of Aluminium.,75,Type_75,No
DB00296,Ropivacaine,DB00715,Paroxetine,0.46217572689056396,49,Type_49,The risk or severity of adverse effects can be increased when Ropivacaine is combined with Paroxetine.,47,Type_47,No
DB00675,Tamoxifen,DB01253,Ergometrine,0.4982224404811859,49,Type_49,The risk or severity of adverse effects can be increased when Tamoxifen is combined with Ergometrine.,49,Type_49,Yes
DB01169,Arsenic trioxide,DB09286,Pipamperone,0.4361136257648468,49,Type_49,The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Pipamperone.,49,Type_49,Yes
DB00772,Malathion,DB05812,Abiraterone,0.4543974697589874,75,Type_75,The serum concentration of Abiraterone can be decreased when it is combined with Malathion.,73,Type_73,No
DB01072,Atazanavir,DB01357,Mestranol,0.4161347448825836,75,Type_75,The serum concentration of Mestranol can be decreased when it is combined with Atazanavir.,75,Type_75,Yes
DB01132,Pioglitazone,DB06287,Temsirolimus,0.4887862801551819,47,Type_47,The metabolism of Temsirolimus can be decreased when combined with Pioglitazone.,70,Type_70,No
DB06605,Apixaban,DB09054,Idelalisib,0.4357745945453644,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Apixaban.,73,Type_73,No
DB01229,Paclitaxel,DB06695,Dabigatran etexilate,0.41798362135887146,49,Type_49,The risk or severity of adverse effects can be increased when Paclitaxel is combined with Dabigatran etexilate.,77,Type_77,No
DB00805,Minaprine,DB01626,Pargyline,0.4559210538864136,71,Type_71,Minaprine may increase the hypertensive activities of Pargyline.,60,Type_60,No
DB00641,Simvastatin,DB01104,Sertraline,0.4981054663658142,73,Type_73,The serum concentration of Sertraline can be increased when it is combined with Simvastatin.,47,Type_47,No
DB01623,Thiothixene,DB09039,Eliglustat,0.31646692752838135,20,Type_20,Thiothixene may increase the QTc-prolonging activities of Eliglustat.,20,Type_20,Yes
DB00559,Bosentan,DB09198,Lobeglitazone,0.4788157045841217,47,Type_47,The metabolism of Lobeglitazone can be decreased when combined with Bosentan.,73,Type_73,No
DB00477,Chlorpromazine,DB00748,Carbinoxamine,0.48707661032676697,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Carbinoxamine.,49,Type_49,Yes
DB00951,Isoniazid,DB01224,Quetiapine,0.4625525176525116,47,Type_47,The metabolism of Quetiapine can be decreased when combined with Isoniazid.,47,Type_47,Yes
DB00590,Doxazosin,DB00951,Isoniazid,0.3449559509754181,47,Type_47,The metabolism of Isoniazid can be decreased when combined with Doxazosin.,47,Type_47,Yes
DB00264,Metoprolol,DB00622,Nicardipine,0.45448383688926697,49,Type_49,The risk or severity of adverse effects can be increased when Metoprolol is combined with Nicardipine.,73,Type_73,No
DB00312,Pentobarbital,DB09099,Somatostatin,0.40384820103645325,4,Type_4,The metabolism of Somatostatin can be increased when combined with Pentobarbital.,49,Type_49,No
DB00224,Indinavir,DB01418,Acenocoumarol,0.4957606792449951,73,Type_73,The serum concentration of Acenocoumarol can be increased when it is combined with Indinavir.,47,Type_47,No
DB01095,Fluvastatin,DB06292,Dapagliflozin,0.4605029821395874,47,Type_47,The metabolism of Dapagliflozin can be decreased when combined with Fluvastatin.,47,Type_47,Yes
DB00279,Liothyronine,DB08918,Levomilnacipran,0.36516261100769043,70,Type_70,The therapeutic efficacy of Levomilnacipran can be decreased when used in combination with Liothyronine.,70,Type_70,Yes
DB00268,Ropinirole,DB01412,Theobromine,0.3825560212135315,73,Type_73,The serum concentration of Theobromine can be increased when it is combined with Ropinirole.,47,Type_47,No
DB00252,Phenytoin,DB00697,Tizanidine,0.43700167536735535,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Tizanidine.,49,Type_49,Yes
DB01420,Testosterone propionate,DB09244,Pirlindole,0.3893924653530121,9,Type_9,Testosterone propionate may increase the hypoglycemic activities of Pirlindole.,49,Type_49,No
DB00933,Mesoridazine,DB04871,Lorcaserin,0.41629502177238464,47,Type_47,The metabolism of Lorcaserin can be decreased when combined with Mesoridazine.,47,Type_47,Yes
DB00834,Mifepristone,DB06791,Lanreotide,0.4552812874317169,73,Type_73,The serum concentration of Lanreotide can be increased when it is combined with Mifepristone.,9,Type_9,No
DB00594,Amiloride,DB01078,Deslanoside,0.4394001364707947,49,Type_49,The risk or severity of adverse effects can be increased when Amiloride is combined with Deslanoside.,70,Type_70,No
DB00651,Dyphylline,DB00817,Rosoxacin,0.45620158314704895,47,Type_47,The metabolism of Rosoxacin can be decreased when combined with Dyphylline.,47,Type_47,Yes
DB00631,Clofarabine,DB09291,Rolapitant,0.4723672866821289,47,Type_47,The metabolism of Rolapitant can be decreased when combined with Clofarabine.,73,Type_73,No
DB00281,Lidocaine,DB00283,Clemastine,0.44127964973449707,49,Type_49,The risk or severity of adverse effects can be increased when Lidocaine is combined with Clemastine.,47,Type_47,No
DB01072,Atazanavir,DB01149,Nefazodone,0.4706474840641022,47,Type_47,The metabolism of Nefazodone can be decreased when combined with Atazanavir.,73,Type_73,No
DB04868,Nilotinib,DB08880,Teriflunomide,0.43326523900032043,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Nilotinib.,73,Type_73,No
DB00908,Quinidine,DB06589,Pazopanib,0.436591237783432,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Quinidine.,73,Type_73,Yes
DB06605,Apixaban,DB08933,Luliconazole,0.49598434567451477,77,Type_77,The serum concentration of the active metabolites of Luliconazole can be increased when Luliconazole is used in combination with Apixaban.,73,Type_73,No
DB06210,Eltrombopag,DB06605,Apixaban,0.44073018431663513,75,Type_75,The serum concentration of Apixaban can be decreased when it is combined with Eltrombopag.,73,Type_73,No
DB00333,Methadone,DB01151,Desipramine,0.4610776901245117,47,Type_47,The metabolism of Desipramine can be decreased when combined with Methadone.,49,Type_49,No
DB00243,Ranolazine,DB00758,Clopidogrel,0.4624336361885071,11,Type_11,The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Ranolazine resulting in a loss in efficacy.,73,Type_73,No
DB01403,Methotrimeprazine,DB08918,Levomilnacipran,0.4870721697807312,49,Type_49,The risk or severity of adverse effects can be increased when Methotrimeprazine is combined with Levomilnacipran.,47,Type_47,No
DB00215,Citalopram,DB00598,Labetalol,0.48433351516723633,73,Type_73,The serum concentration of Labetalol can be increased when it is combined with Citalopram.,47,Type_47,No
DB01208,Sparfloxacin,DB01397,Magnesium salicylate,0.43401485681533813,49,Type_49,The risk or severity of adverse effects can be increased when Sparfloxacin is combined with Magnesium salicylate.,75,Type_75,No
DB00398,Sorafenib,DB00738,Pentamidine,0.3587149381637573,20,Type_20,Sorafenib may increase the QTc-prolonging activities of Pentamidine.,20,Type_20,Yes
DB00244,Mesalazine,DB01166,Cilostazol,0.31851857900619507,9,Type_9,Mesalazine may increase the hypoglycemic activities of Cilostazol.,49,Type_49,No
DB00187,Esmolol,DB00211,Midodrine,0.3117651343345642,49,Type_49,The risk or severity of adverse effects can be increased when Esmolol is combined with Midodrine.,54,Type_54,No
DB00755,Tretinoin,DB05812,Abiraterone,0.4949549734592438,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Tretinoin.,73,Type_73,No
DB06287,Temsirolimus,DB06335,Saxagliptin,0.40171462297439575,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Temsirolimus.,49,Type_49,No
DB00278,Argatroban,DB00890,Dienestrol,0.33552905917167664,12,Type_12,Argatroban may decrease the anticoagulant activities of Dienestrol.,75,Type_75,No
DB00582,Voriconazole,DB01624,Zuclopenthixol,0.3918531537055969,73,Type_73,The serum concentration of Zuclopenthixol can be increased when it is combined with Voriconazole.,73,Type_73,Yes
DB00907,Cocaine,DB01244,Bepridil,0.4198947250843048,47,Type_47,The metabolism of Bepridil can be decreased when combined with Cocaine.,47,Type_47,Yes
DB00343,Diltiazem,DB00390,Digoxin,0.42858272790908813,25,Type_25,Diltiazem may increase the atrioventricular blocking (AV block) activities of Digoxin.,47,Type_47,No
DB00203,Sildenafil,DB01180,Rescinnamine,0.48995113372802734,73,Type_73,The serum concentration of Rescinnamine can be increased when it is combined with Sildenafil.,10,Type_10,No
DB00482,Celecoxib,DB00598,Labetalol,0.49911436438560486,47,Type_47,The metabolism of Labetalol can be decreased when combined with Celecoxib.,47,Type_47,Yes
DB00398,Sorafenib,DB04898,Ximelagatran,0.4864218831062317,73,Type_73,The serum concentration of Ximelagatran can be increased when it is combined with Sorafenib.,47,Type_47,No
DB00622,Nicardipine,DB04839,Cyproterone acetate,0.4960002303123474,73,Type_73,The serum concentration of Cyproterone acetate can be increased when it is combined with Nicardipine.,75,Type_75,No
DB01194,Brinzolamide,DB01356,Lithium cation,0.4453910291194916,49,Type_49,The risk or severity of adverse effects can be increased when Brinzolamide is combined with Lithium cation.,75,Type_75,No
DB00375,Colestipol,DB01418,Acenocoumarol,0.3572511374950409,75,Type_75,The serum concentration of Acenocoumarol can be decreased when it is combined with Colestipol.,67,Type_67,No
DB00346,Alfuzosin,DB00489,Sotalol,0.4968074560165405,30,Type_30,Alfuzosin may increase the orthostatic hypotensive activities of Sotalol.,20,Type_20,No
DB00346,Alfuzosin,DB00697,Tizanidine,0.48596829175949097,20,Type_20,Alfuzosin may increase the QTc-prolonging activities of Tizanidine.,5,Type_5,No
DB00477,Chlorpromazine,DB01227,Levacetylmethadol,0.4411328434944153,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Levacetylmethadol.,49,Type_49,Yes
DB00270,Isradipine,DB00678,Losartan,0.4875442385673523,47,Type_47,The metabolism of Losartan can be decreased when combined with Isradipine.,49,Type_49,No
DB00346,Alfuzosin,DB06203,Alogliptin,0.4908507466316223,47,Type_47,The metabolism of Alogliptin can be decreased when combined with Alfuzosin.,73,Type_73,No
DB00294,Etonogestrel,DB01254,Dasatinib,0.4117869734764099,47,Type_47,The metabolism of Dasatinib can be decreased when combined with Etonogestrel.,73,Type_73,No
DB01274,Arformoterol,DB08881,Vemurafenib,0.34577423334121704,33,Type_33,The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Vemurafenib.,33,Type_33,Yes
DB01167,Itraconazole,DB06414,Etravirine,0.4809521734714508,73,Type_73,The serum concentration of Etravirine can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB01621,Pipotiazine,DB08881,Vemurafenib,0.49889588356018066,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Pipotiazine.,73,Type_73,Yes
DB01115,Nifedipine,DB06335,Saxagliptin,0.35159146785736084,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Nifedipine.,75,Type_75,No
DB00184,Nicotine,DB00989,Rivastigmine,0.3552706837654114,49,Type_49,The risk or severity of adverse effects can be increased when Nicotine is combined with Rivastigmine.,49,Type_49,Yes
DB00238,Nevirapine,DB00745,Modafinil,0.48761677742004395,47,Type_47,The metabolism of Modafinil can be decreased when combined with Nevirapine.,4,Type_4,No
DB00334,Olanzapine,DB01066,Cefditoren,0.38558200001716614,67,Type_67,Olanzapine can cause a decrease in the absorption of Cefditoren resulting in a reduced serum concentration and potentially a decrease in efficacy.,75,Type_75,No
DB00907,Cocaine,DB01100,Pimozide,0.4328433871269226,49,Type_49,The risk or severity of adverse effects can be increased when Cocaine is combined with Pimozide.,73,Type_73,No
DB00678,Losartan,DB08439,Parecoxib,0.48284581303596497,47,Type_47,The metabolism of Parecoxib can be decreased when combined with Losartan.,47,Type_47,Yes
DB00705,Delavirdine,DB01418,Acenocoumarol,0.49268120527267456,73,Type_73,The serum concentration of Acenocoumarol can be increased when it is combined with Delavirdine.,47,Type_47,No
DB00252,Phenytoin,DB01511,Delorazepam,0.48583173751831055,75,Type_75,The serum concentration of Delorazepam can be decreased when it is combined with Phenytoin.,73,Type_73,No
DB00270,Isradipine,DB00877,Sirolimus,0.4982134997844696,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Sirolimus.,49,Type_49,Yes
DB00744,Zileuton,DB00917,Dinoprostone,0.30627015233039856,49,Type_49,The risk or severity of adverse effects can be increased when Zileuton is combined with Dinoprostone.,70,Type_70,No
DB04743,Nimesulide,DB08816,Ticagrelor,0.36220717430114746,6,Type_6,Nimesulide may increase the anticoagulant activities of Ticagrelor.,6,Type_6,Yes
DB00270,Isradipine,DB01186,Pergolide,0.3398345708847046,49,Type_49,The risk or severity of adverse effects can be increased when Isradipine is combined with Pergolide.,47,Type_47,No
DB00244,Mesalazine,DB00927,Famotidine,0.405149906873703,57,Type_57,Mesalazine may increase the nephrotoxic activities of Famotidine.,70,Type_70,No
DB00715,Paroxetine,DB00794,Primidone,0.39377593994140625,4,Type_4,The metabolism of Primidone can be increased when combined with Paroxetine.,49,Type_49,No
DB00615,Rifabutin,DB00977,Ethinylestradiol,0.47698721289634705,75,Type_75,The serum concentration of Ethinylestradiol can be decreased when it is combined with Rifabutin.,4,Type_4,No
DB00808,Indapamide,DB01100,Pimozide,0.4987153708934784,49,Type_49,The risk or severity of adverse effects can be increased when Indapamide is combined with Pimozide.,20,Type_20,No
DB01016,Glyburide,DB01110,Miconazole,0.3781884014606476,49,Type_49,The risk or severity of adverse effects can be increased when Glyburide is combined with Miconazole.,9,Type_9,No
DB00215,Citalopram,DB01018,Guanfacine,0.4964402914047241,47,Type_47,The metabolism of Guanfacine can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00705,Delavirdine,DB06626,Axitinib,0.4752742052078247,47,Type_47,The metabolism of Axitinib can be decreased when combined with Delavirdine.,47,Type_47,Yes
DB00175,Pravastatin,DB00481,Raloxifene,0.4957036077976227,73,Type_73,The serum concentration of Raloxifene can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB00946,Phenprocoumon,DB01132,Pioglitazone,0.2938627302646637,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Phenprocoumon.,47,Type_47,Yes
DB00541,Vincristine,DB00655,Estrone,0.49247416853904724,73,Type_73,The serum concentration of Estrone can be increased when it is combined with Vincristine.,75,Type_75,No
DB01104,Sertraline,DB01195,Flecainide,0.3874147832393646,20,Type_20,Sertraline may increase the QTc-prolonging activities of Flecainide.,20,Type_20,Yes
DB00402,Eszopiclone,DB01095,Fluvastatin,0.4918714463710785,47,Type_47,The metabolism of Fluvastatin can be decreased when combined with Eszopiclone.,47,Type_47,Yes
DB06702,Fesoterodine,DB09330,Osimertinib,0.4816668629646301,73,Type_73,The serum concentration of Osimertinib can be increased when it is combined with Fesoterodine.,73,Type_73,Yes
DB00321,Amitriptyline,DB00701,Amprenavir,0.44561222195625305,47,Type_47,The metabolism of Amprenavir can be decreased when combined with Amitriptyline.,73,Type_73,No
DB01182,Propafenone,DB04868,Nilotinib,0.43018263578414917,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Propafenone.,73,Type_73,No
DB00224,Indinavir,DB00977,Ethinylestradiol,0.3853393793106079,47,Type_47,The metabolism of Ethinylestradiol can be decreased when combined with Indinavir.,47,Type_47,Yes
DB00313,Valproic acid,DB01018,Guanfacine,0.484772264957428,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Guanfacine.,73,Type_73,No
DB00285,Venlafaxine,DB00949,Felbamate,0.4544563591480255,47,Type_47,The metabolism of Felbamate can be decreased when combined with Venlafaxine.,47,Type_47,Yes
DB00268,Ropinirole,DB04839,Cyproterone acetate,0.4932258129119873,73,Type_73,The serum concentration of Cyproterone acetate can be increased when it is combined with Ropinirole.,75,Type_75,No
DB00220,Nelfinavir,DB00916,Metronidazole,0.37367695569992065,73,Type_73,The serum concentration of Metronidazole can be increased when it is combined with Nelfinavir.,47,Type_47,No
DB01118,Amiodarone,DB09078,Lenvatinib,0.4084011912345886,20,Type_20,Amiodarone may increase the QTc-prolonging activities of Lenvatinib.,47,Type_47,No
DB01219,Dantrolene,DB09280,Lumacaftor,0.45876064896583557,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Dantrolene.,4,Type_4,No
DB00768,Olopatadine,DB00917,Dinoprostone,0.4736883044242859,73,Type_73,The serum concentration of Dinoprostone can be increased when it is combined with Olopatadine.,70,Type_70,No
DB00199,Erythromycin,DB01195,Flecainide,0.41962191462516785,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Flecainide.,20,Type_20,Yes
DB00319,Piperacillin,DB00946,Phenprocoumon,0.46346813440322876,6,Type_6,Piperacillin may increase the anticoagulant activities of Phenprocoumon.,6,Type_6,Yes
DB00227,Lovastatin,DB00780,Phenelzine,0.4458082616329193,73,Type_73,The serum concentration of Phenelzine can be increased when it is combined with Lovastatin.,73,Type_73,Yes
DB00866,Alprenolol,DB01193,Acebutolol,0.47576236724853516,14,Type_14,Alprenolol may decrease the bronchodilatory activities of Acebutolol.,60,Type_60,No
DB01167,Itraconazole,DB09078,Lenvatinib,0.4009895622730255,47,Type_47,The metabolism of Lenvatinib can be decreased when combined with Itraconazole.,47,Type_47,Yes
DB00346,Alfuzosin,DB00678,Losartan,0.46320605278015137,60,Type_60,Alfuzosin may increase the hypotensive activities of Losartan.,60,Type_60,Yes
DB00343,Diltiazem,DB01037,Selegiline,0.3870936334133148,47,Type_47,The metabolism of Selegiline can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB01200,Bromocriptine,DB01242,Clomipramine,0.49975329637527466,37,Type_37,Bromocriptine may decrease the antihypertensive activities of Clomipramine.,37,Type_37,Yes
DB00653,Magnesium sulfate,DB09238,Manidipine,0.27120718359947205,47,Type_47,The metabolism of Manidipine can be decreased when combined with Magnesium sulfate.,49,Type_49,No
DB00367,Levonorgestrel,DB01154,Thiamylal,0.4142844080924988,70,Type_70,The therapeutic efficacy of Thiamylal can be decreased when used in combination with Levonorgestrel.,70,Type_70,Yes
DB00564,Carbamazepine,DB00691,Moexipril,0.34022611379623413,75,Type_75,The serum concentration of Moexipril can be decreased when it is combined with Carbamazepine.,4,Type_4,No
DB00361,Vinorelbine,DB01072,Atazanavir,0.4570200741291046,73,Type_73,The serum concentration of Atazanavir can be increased when it is combined with Vinorelbine.,47,Type_47,No
DB00343,Diltiazem,DB01250,Olsalazine,0.36814549565315247,49,Type_49,The risk or severity of adverse effects can be increased when Diltiazem is combined with Olsalazine.,6,Type_6,No
DB00751,Epinastine,DB01072,Atazanavir,0.46455392241477966,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Epinastine.,75,Type_75,No
DB00472,Fluoxetine,DB01171,Moclobemide,0.41628700494766235,49,Type_49,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Moclobemide.,47,Type_47,No
DB01254,Dasatinib,DB09082,Vilanterol,0.4282183051109314,20,Type_20,Dasatinib may increase the QTc-prolonging activities of Vilanterol.,73,Type_73,No
DB00578,Carbenicillin,DB01024,Mycophenolic acid,0.4775785505771637,75,Type_75,The serum concentration of Mycophenolic acid can be decreased when it is combined with Carbenicillin.,11,Type_11,No
DB00476,Duloxetine,DB00641,Simvastatin,0.4142782688140869,73,Type_73,The serum concentration of Simvastatin can be increased when it is combined with Duloxetine.,47,Type_47,No
DB06702,Fesoterodine,DB09238,Manidipine,0.4112319052219391,77,Type_77,The serum concentration of the active metabolites of Manidipine can be increased when Manidipine is used in combination with Fesoterodine.,77,Type_77,Yes
DB00207,Azithromycin,DB00498,Phenindione,0.4111441671848297,73,Type_73,The serum concentration of Phenindione can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB00393,Nimodipine,DB00908,Quinidine,0.3891838788986206,47,Type_47,The metabolism of Quinidine can be decreased when combined with Nimodipine.,75,Type_75,No
DB00398,Sorafenib,DB01624,Zuclopenthixol,0.48674556612968445,20,Type_20,Sorafenib may increase the QTc-prolonging activities of Zuclopenthixol.,20,Type_20,Yes
DB00214,Torasemide,DB00390,Digoxin,0.48130372166633606,70,Type_70,The therapeutic efficacy of Digoxin can be decreased when used in combination with Torasemide.,49,Type_49,No
DB01141,Micafungin,DB01591,Solifenacin,0.4908239245414734,47,Type_47,The metabolism of Solifenacin can be decreased when combined with Micafungin.,47,Type_47,Yes
DB00254,Doxycycline,DB08795,Azidocillin,0.2946270704269409,70,Type_70,The therapeutic efficacy of Azidocillin can be decreased when used in combination with Doxycycline.,70,Type_70,Yes
DB00273,Topiramate,DB00682,Warfarin,0.4851406514644623,6,Type_6,Topiramate may increase the anticoagulant activities of Warfarin.,47,Type_47,No
DB01234,Dexamethasone,DB04868,Nilotinib,0.42733708024024963,47,Type_47,The metabolism of Nilotinib can be decreased when combined with Dexamethasone.,75,Type_75,No
DB01656,Roflumilast,DB08910,Pomalidomide,0.27808138728141785,47,Type_47,The metabolism of Pomalidomide can be decreased when combined with Roflumilast.,34,Type_34,No
DB00215,Citalopram,DB06605,Apixaban,0.4382563531398773,47,Type_47,The metabolism of Apixaban can be decreased when combined with Citalopram.,47,Type_47,Yes
DB00477,Chlorpromazine,DB00637,Astemizole,0.44893258810043335,20,Type_20,Chlorpromazine may increase the QTc-prolonging activities of Astemizole.,47,Type_47,No
DB00563,Methotrexate,DB09320,Procaine benzylpenicillin,0.41366907954216003,70,Type_70,The therapeutic efficacy of Procaine benzylpenicillin can be decreased when used in combination with Methotrexate.,73,Type_73,No
DB01319,Fosamprenavir,DB09054,Idelalisib,0.4758906960487366,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Fosamprenavir.,47,Type_47,Yes
DB00625,Efavirenz,DB06210,Eltrombopag,0.46533751487731934,47,Type_47,The metabolism of Eltrombopag can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB01118,Amiodarone,DB01601,Lopinavir,0.4990207552909851,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Amiodarone.,20,Type_20,No
DB00295,Morphine,DB00625,Efavirenz,0.32908153533935547,47,Type_47,The metabolism of Efavirenz can be decreased when combined with Morphine.,49,Type_49,No
DB01142,Doxepin,DB09570,Ixazomib,0.45929601788520813,73,Type_73,The serum concentration of Ixazomib can be increased when it is combined with Doxepin.,73,Type_73,Yes
DB00673,Aprepitant,DB01355,Hexobarbital,0.4892357289791107,4,Type_4,The metabolism of Hexobarbital can be increased when combined with Aprepitant.,73,Type_73,No
DB00175,Pravastatin,DB00647,Dextropropoxyphene,0.49493926763534546,47,Type_47,The metabolism of Dextropropoxyphene can be decreased when combined with Pravastatin.,73,Type_73,No
DB00176,Fluvoxamine,DB00559,Bosentan,0.48933520913124084,73,Type_73,The serum concentration of Bosentan can be increased when it is combined with Fluvoxamine.,73,Type_73,Yes
DB01104,Sertraline,DB01295,Bevantolol,0.465379923582077,73,Type_73,The serum concentration of Bevantolol can be increased when it is combined with Sertraline.,73,Type_73,Yes
DB01166,Cilostazol,DB01601,Lopinavir,0.4584724009037018,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Cilostazol.,73,Type_73,Yes
DB00458,Imipramine,DB09204,Arotinolol,0.49883946776390076,73,Type_73,The serum concentration of Arotinolol can be increased when it is combined with Imipramine.,49,Type_49,No
DB00472,Fluoxetine,DB01295,Bevantolol,0.32829174399375916,73,Type_73,The serum concentration of Bevantolol can be increased when it is combined with Fluoxetine.,73,Type_73,Yes
DB00313,Valproic acid,DB00752,Tranylcypromine,0.4600810408592224,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Tranylcypromine.,49,Type_49,Yes
DB00502,Haloperidol,DB08909,Glycerol phenylbutyrate,0.4326418936252594,49,Type_49,The risk or severity of adverse effects can be increased when Haloperidol is combined with Glycerol phenylbutyrate.,70,Type_70,No
DB00661,Verapamil,DB01348,Spirapril,0.4500771462917328,49,Type_49,The risk or severity of adverse effects can be increased when Verapamil is combined with Spirapril.,47,Type_47,No
DB00987,Cytarabine,DB01097,Leflunomide,0.4637736678123474,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Cytarabine.,49,Type_49,No
DB00751,Epinastine,DB00972,Azelastine,0.3621937334537506,76,Type_76,Epinastine may decrease the sedative activities of Azelastine.,53,Type_53,No
DB00564,Carbamazepine,DB00651,Dyphylline,0.30339157581329346,70,Type_70,The therapeutic efficacy of Dyphylline can be decreased when used in combination with Carbamazepine.,75,Type_75,No
DB00243,Ranolazine,DB00283,Clemastine,0.44686099886894226,73,Type_73,The serum concentration of Clemastine can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB01044,Gatifloxacin,DB01223,Aminophylline,0.32244259119033813,70,Type_70,The therapeutic efficacy of Aminophylline can be decreased when used in combination with Gatifloxacin.,47,Type_47,No
DB00257,Clotrimazole,DB01320,Fosphenytoin,0.4342668652534485,73,Type_73,The serum concentration of Fosphenytoin can be increased when it is combined with Clotrimazole.,75,Type_75,No
DB00363,Clozapine,DB00568,Cinnarizine,0.4790937006473541,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Cinnarizine.,47,Type_47,No
DB00916,Metronidazole,DB00976,Telithromycin,0.49516260623931885,20,Type_20,Metronidazole may increase the QTc-prolonging activities of Telithromycin.,47,Type_47,No
DB01407,Clenbuterol,DB08880,Teriflunomide,0.46232765913009644,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Clenbuterol.,75,Type_75,Yes
DB08895,Tofacitinib,DB11921,Deflazacort,0.43271633982658386,34,Type_34,Tofacitinib may increase the immunosuppressive activities of Deflazacort.,34,Type_34,Yes
DB00474,Methohexital,DB01229,Paclitaxel,0.4202863574028015,60,Type_60,Methohexital may increase the hypotensive activities of Paclitaxel.,60,Type_60,Yes
DB00312,Pentobarbital,DB01656,Roflumilast,0.4260731339454651,4,Type_4,The metabolism of Roflumilast can be increased when combined with Pentobarbital.,75,Type_75,No
DB00227,Lovastatin,DB12001,Abemaciclib,0.49276912212371826,47,Type_47,The metabolism of Abemaciclib can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00280,Disopyramide,DB01015,Sulfamethoxazole,0.4335392415523529,20,Type_20,Disopyramide may increase the QTc-prolonging activities of Sulfamethoxazole.,20,Type_20,Yes
DB01200,Bromocriptine,DB01234,Dexamethasone,0.4581923186779022,49,Type_49,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Dexamethasone.,49,Type_49,Yes
DB00184,Nicotine,DB04846,Celiprolol,0.46517619490623474,49,Type_49,The risk or severity of adverse effects can be increased when Nicotine is combined with Celiprolol.,49,Type_49,Yes
DB01242,Clomipramine,DB08880,Teriflunomide,0.48837515711784363,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Clomipramine.,75,Type_75,Yes
DB00320,Dihydroergotamine,DB01018,Guanfacine,0.45288681983947754,47,Type_47,The metabolism of Guanfacine can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00641,Simvastatin,DB00864,Tacrolimus,0.35464709997177124,48,Type_48,Simvastatin may increase the myopathic rhabdomyolysis activities of Tacrolimus.,73,Type_73,No
DB00976,Telithromycin,DB06697,Artemether,0.4262714982032776,73,Type_73,The serum concentration of Artemether can be increased when it is combined with Telithromycin.,47,Type_47,No
DB01074,Perhexiline,DB01403,Methotrimeprazine,0.47145143151283264,73,Type_73,The serum concentration of Methotrimeprazine can be increased when it is combined with Perhexiline.,47,Type_47,No
DB00178,Ramipril,DB00454,Meperidine,0.39160382747650146,49,Type_49,The risk or severity of adverse effects can be increased when Ramipril is combined with Meperidine.,49,Type_49,Yes
DB00312,Pentobarbital,DB01068,Clonazepam,0.4897468388080597,4,Type_4,The metabolism of Clonazepam can be increased when combined with Pentobarbital.,4,Type_4,Yes
DB00320,Dihydroergotamine,DB00734,Risperidone,0.46128779649734497,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Risperidone.,47,Type_47,No
DB00738,Pentamidine,DB08918,Levomilnacipran,0.37130507826805115,49,Type_49,The risk or severity of adverse effects can be increased when Pentamidine is combined with Levomilnacipran.,9,Type_9,No
DB00283,Clemastine,DB06603,Panobinostat,0.44905391335487366,73,Type_73,The serum concentration of Panobinostat can be increased when it is combined with Clemastine.,47,Type_47,No
DB00283,Clemastine,DB00934,Maprotiline,0.48366719484329224,49,Type_49,The risk or severity of adverse effects can be increased when Clemastine is combined with Maprotiline.,47,Type_47,No
DB00468,Quinine,DB01261,Sitagliptin,0.47972261905670166,9,Type_9,Quinine may increase the hypoglycemic activities of Sitagliptin.,47,Type_47,No
DB08865,Crizotinib,DB09280,Lumacaftor,0.49149996042251587,73,Type_73,The serum concentration of Lumacaftor can be increased when it is combined with Crizotinib.,75,Type_75,No
DB00908,Quinidine,DB11315,Methscopolamine,0.41212141513824463,2,Type_2,Quinidine may increase the anticholinergic activities of Methscopolamine.,49,Type_49,No
DB01435,Antipyrine,DB01589,Quazepam,0.4965810775756836,49,Type_49,The risk or severity of adverse effects can be increased when Antipyrine is combined with Quazepam.,73,Type_73,No
DB00477,Chlorpromazine,DB00726,Trimipramine,0.32252684235572815,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Chlorpromazine.,20,Type_20,No
DB00199,Erythromycin,DB01403,Methotrimeprazine,0.4422667622566223,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Methotrimeprazine.,20,Type_20,Yes
DB00343,Diltiazem,DB01268,Sunitinib,0.33795735239982605,47,Type_47,The metabolism of Sunitinib can be decreased when combined with Diltiazem.,47,Type_47,Yes
DB00091,Cyclosporine,DB00264,Metoprolol,0.4962811768054962,47,Type_47,The metabolism of Metoprolol can be decreased when combined with Cyclosporine.,73,Type_73,No
DB00498,Phenindione,DB01609,Deferasirox,0.4582441747188568,75,Type_75,The serum concentration of Deferasirox can be decreased when it is combined with Phenindione.,49,Type_49,No
DB00590,Doxazosin,DB00697,Tizanidine,0.35851263999938965,49,Type_49,The risk or severity of adverse effects can be increased when Doxazosin is combined with Tizanidine.,49,Type_49,Yes
DB00682,Warfarin,DB01072,Atazanavir,0.4213685393333435,6,Type_6,Warfarin may increase the anticoagulant activities of Atazanavir.,73,Type_73,No
DB01609,Deferasirox,DB09053,Ibrutinib,0.4973165988922119,73,Type_73,The serum concentration of Ibrutinib can be increased when it is combined with Deferasirox.,75,Type_75,No
DB01104,Sertraline,DB06216,Asenapine,0.41604137420654297,20,Type_20,Sertraline may increase the QTc-prolonging activities of Asenapine.,20,Type_20,Yes
DB00270,Isradipine,DB00559,Bosentan,0.37373054027557373,73,Type_73,The serum concentration of Bosentan can be increased when it is combined with Isradipine.,73,Type_73,Yes
DB00794,Primidone,DB00808,Indapamide,0.4135405123233795,60,Type_60,Primidone may increase the hypotensive activities of Indapamide.,4,Type_4,No
DB00924,Cyclobenzaprine,DB01118,Amiodarone,0.3786441683769226,20,Type_20,Cyclobenzaprine may increase the QTc-prolonging activities of Amiodarone.,47,Type_47,No
DB09244,Pirlindole,DB09289,Tianeptine,0.44777989387512207,49,Type_49,The risk or severity of adverse effects can be increased when Pirlindole is combined with Tianeptine.,49,Type_49,Yes
DB00420,Promazine,DB01264,Darunavir,0.4960116147994995,47,Type_47,The metabolism of Darunavir can be decreased when combined with Promazine.,47,Type_47,Yes
DB01186,Pergolide,DB01263,Posaconazole,0.46183034777641296,49,Type_49,The risk or severity of adverse effects can be increased when Pergolide is combined with Posaconazole.,47,Type_47,No
DB00625,Efavirenz,DB00843,Donepezil,0.49396881461143494,47,Type_47,The metabolism of Donepezil can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB00949,Felbamate,DB04868,Nilotinib,0.44165998697280884,20,Type_20,Felbamate may increase the QTc-prolonging activities of Nilotinib.,20,Type_20,Yes
DB08883,Perampanel,DB09054,Idelalisib,0.4278528094291687,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Perampanel.,47,Type_47,Yes
DB00679,Thioridazine,DB06148,Mianserin,0.28801095485687256,47,Type_47,The metabolism of Mianserin can be decreased when combined with Thioridazine.,73,Type_73,No
DB00881,Quinapril,DB01137,Levofloxacin,0.4703393280506134,49,Type_49,The risk or severity of adverse effects can be increased when Quinapril is combined with Levofloxacin.,75,Type_75,No
DB00498,Phenindione,DB09256,Tegafur,0.4671919047832489,70,Type_70,The therapeutic efficacy of Tegafur can be decreased when used in combination with Phenindione.,73,Type_73,No
DB00625,Efavirenz,DB09270,Ubidecarenone,0.4744206964969635,73,Type_73,The serum concentration of Ubidecarenone can be increased when it is combined with Efavirenz.,73,Type_73,Yes
DB00273,Topiramate,DB06335,Saxagliptin,0.4544481337070465,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Topiramate.,75,Type_75,No
DB00266,Dicoumarol,DB00440,Trimethoprim,0.48112842440605164,47,Type_47,The metabolism of Trimethoprim can be decreased when combined with Dicoumarol.,47,Type_47,Yes
DB00540,Nortriptyline,DB01124,Tolbutamide,0.4236929714679718,73,Type_73,The serum concentration of Tolbutamide can be increased when it is combined with Nortriptyline.,47,Type_47,No
DB00653,Magnesium sulfate,DB01208,Sparfloxacin,0.4934200644493103,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Sparfloxacin.,75,Type_75,No
DB00333,Methadone,DB00641,Simvastatin,0.4414398968219757,73,Type_73,The serum concentration of Simvastatin can be increased when it is combined with Methadone.,47,Type_47,No
DB00477,Chlorpromazine,DB01023,Felodipine,0.48749497532844543,49,Type_49,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Felodipine.,49,Type_49,Yes
DB00476,Duloxetine,DB00753,Isoflurane,0.4642266035079956,30,Type_30,Duloxetine may increase the orthostatic hypotensive activities of Isoflurane.,30,Type_30,Yes
DB00307,Bexarotene,DB01196,Estramustine,0.34019920229911804,75,Type_75,The serum concentration of Estramustine can be decreased when it is combined with Bexarotene.,75,Type_75,Yes
DB00531,Cyclophosphamide,DB00701,Amprenavir,0.3974050283432007,47,Type_47,The metabolism of Amprenavir can be decreased when combined with Cyclophosphamide.,49,Type_49,No
DB00238,Nevirapine,DB00367,Levonorgestrel,0.4009552597999573,4,Type_4,The metabolism of Levonorgestrel can be increased when combined with Nevirapine.,75,Type_75,No
DB00709,Lamivudine,DB00811,Ribavirin,0.4394475817680359,73,Type_73,The serum concentration of Ribavirin can be increased when it is combined with Lamivudine.,80,Type_80,No
DB00252,Phenytoin,DB00400,Griseofulvin,0.40946075320243835,73,Type_73,The serum concentration of Griseofulvin can be increased when it is combined with Phenytoin.,73,Type_73,Yes
DB00904,Ondansetron,DB01224,Quetiapine,0.4707193076610565,20,Type_20,Ondansetron may increase the QTc-prolonging activities of Quetiapine.,49,Type_49,No
DB00682,Warfarin,DB00763,Methimazole,0.3394901752471924,12,Type_12,Warfarin may decrease the anticoagulant activities of Methimazole.,12,Type_12,Yes
DB06210,Eltrombopag,DB12026,Voxilaprevir,0.4978052079677582,47,Type_47,The metabolism of Voxilaprevir can be decreased when combined with Eltrombopag.,73,Type_73,No
DB00333,Methadone,DB04844,Tetrabenazine,0.4843218922615051,20,Type_20,Methadone may increase the QTc-prolonging activities of Tetrabenazine.,47,Type_47,No
DB01095,Fluvastatin,DB05541,Brivaracetam,0.4435805082321167,73,Type_73,The serum concentration of Brivaracetam can be increased when it is combined with Fluvastatin.,47,Type_47,No
DB01136,Carvedilol,DB01224,Quetiapine,0.4645697772502899,49,Type_49,The risk or severity of adverse effects can be increased when Carvedilol is combined with Quetiapine.,49,Type_49,Yes
DB00238,Nevirapine,DB01211,Clarithromycin,0.31637850403785706,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Nevirapine.,77,Type_77,No
DB00503,Ritonavir,DB01403,Methotrimeprazine,0.3978908956050873,73,Type_73,The serum concentration of Methotrimeprazine can be increased when it is combined with Ritonavir.,47,Type_47,No
DB01196,Estramustine,DB13231,Calcium lactate,0.4220813810825348,72,Type_72,Estramustine may decrease the excretion rate of Calcium lactate which could result in a higher serum level.,67,Type_67,No
DB00564,Carbamazepine,DB09280,Lumacaftor,0.49752476811408997,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Carbamazepine.,73,Type_73,No
DB00418,Secobarbital,DB00530,Erlotinib,0.4881499409675598,4,Type_4,The metabolism of Erlotinib can be increased when combined with Secobarbital.,4,Type_4,Yes
DB00627,Niacin,DB00898,Ethanol,0.48737767338752747,75,Type_75,The serum concentration of Ethanol can be decreased when it is combined with Niacin.,49,Type_49,No
DB00968,Methyldopa,DB08808,Bupranolol,0.39494529366493225,25,Type_25,Methyldopa may increase the atrioventricular blocking (AV block) activities of Bupranolol.,60,Type_60,No
DB00270,Isradipine,DB01396,Digitoxin,0.48347151279449463,47,Type_47,The metabolism of Digitoxin can be decreased when combined with Isradipine.,47,Type_47,Yes
DB00459,Acitretin,DB01395,Drospirenone,0.498473197221756,70,Type_70,The therapeutic efficacy of Drospirenone can be decreased when used in combination with Acitretin.,70,Type_70,Yes
DB01166,Cilostazol,DB01241,Gemfibrozil,0.47305309772491455,47,Type_47,The metabolism of Gemfibrozil can be decreased when combined with Cilostazol.,73,Type_73,No
DB01406,Danazol,DB08907,Canagliflozin,0.28333625197410583,70,Type_70,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Danazol.,70,Type_70,Yes
DB00678,Losartan,DB01240,Epoprostenol,0.48564863204956055,49,Type_49,The risk or severity of adverse effects can be increased when Losartan is combined with Epoprostenol.,47,Type_47,No
DB01197,Captopril,DB01220,Rifaximin,0.4424229860305786,75,Type_75,The serum concentration of Rifaximin can be decreased when it is combined with Captopril.,73,Type_73,No
DB01028,Methoxyflurane,DB01104,Sertraline,0.49795040488243103,49,Type_49,The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Sertraline.,47,Type_47,No
DB00335,Atenolol,DB00661,Verapamil,0.44676101207733154,49,Type_49,The risk or severity of adverse effects can be increased when Atenolol is combined with Verapamil.,49,Type_49,Yes
DB00796,Candesartan cilexetil,DB01095,Fluvastatin,0.43227729201316833,73,Type_73,The serum concentration of Fluvastatin can be increased when it is combined with Candesartan cilexetil.,47,Type_47,No
DB00819,Acetazolamide,DB01194,Brinzolamide,0.4949164390563965,49,Type_49,The risk or severity of adverse effects can be increased when Acetazolamide is combined with Brinzolamide.,49,Type_49,Yes
DB00834,Mifepristone,DB01174,Phenobarbital,0.4216444194316864,75,Type_75,The serum concentration of Phenobarbital can be decreased when it is combined with Mifepristone.,73,Type_73,No
DB00227,Lovastatin,DB00738,Pentamidine,0.3957933187484741,47,Type_47,The metabolism of Pentamidine can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00285,Venlafaxine,DB00555,Lamotrigine,0.466433048248291,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lamotrigine.,49,Type_49,Yes
DB00246,Ziprasidone,DB00396,Progesterone,0.4664483070373535,47,Type_47,The metabolism of Progesterone can be decreased when combined with Ziprasidone.,47,Type_47,Yes
DB00557,Hydroxyzine,DB01601,Lopinavir,0.4198399484157562,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Hydroxyzine.,20,Type_20,No
DB04855,Dronedarone,DB05294,Vandetanib,0.3413969874382019,73,Type_73,The serum concentration of Vandetanib can be increased when it is combined with Dronedarone.,47,Type_47,No
DB00281,Lidocaine,DB00924,Cyclobenzaprine,0.47488638758659363,47,Type_47,The metabolism of Cyclobenzaprine can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB06144,Sertindole,DB08873,Boceprevir,0.4847697615623474,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Sertindole.,47,Type_47,No
DB08868,Fingolimod,DB09063,Ceritinib,0.4526330232620239,54,Type_54,Fingolimod may increase the bradycardic activities of Ceritinib.,73,Type_73,No
DB00734,Risperidone,DB00975,Dipyridamole,0.4554438889026642,60,Type_60,Risperidone may increase the hypotensive activities of Dipyridamole.,60,Type_60,Yes
DB00334,Olanzapine,DB00514,Dextromethorphan,0.42998552322387695,47,Type_47,The metabolism of Dextromethorphan can be decreased when combined with Olanzapine.,49,Type_49,No
DB00734,Risperidone,DB01023,Felodipine,0.31799569725990295,47,Type_47,The metabolism of Felodipine can be decreased when combined with Risperidone.,60,Type_60,No
DB00289,Atomoxetine,DB00637,Astemizole,0.47345978021621704,47,Type_47,The metabolism of Astemizole can be decreased when combined with Atomoxetine.,47,Type_47,Yes
DB00817,Rosoxacin,DB01223,Aminophylline,0.35351186990737915,73,Type_73,The serum concentration of Aminophylline can be increased when it is combined with Rosoxacin.,47,Type_47,No
DB00264,Metoprolol,DB06708,Lumefantrine,0.4927603304386139,47,Type_47,The metabolism of Lumefantrine can be decreased when combined with Metoprolol.,73,Type_73,No
DB00238,Nevirapine,DB00619,Imatinib,0.34863054752349854,47,Type_47,The metabolism of Imatinib can be decreased when combined with Nevirapine.,75,Type_75,No
DB00184,Nicotine,DB00571,Propranolol,0.49085626006126404,49,Type_49,The risk or severity of adverse effects can be increased when Nicotine is combined with Propranolol.,49,Type_49,Yes
DB00235,Milrinone,DB00244,Mesalazine,0.4032706916332245,6,Type_6,Milrinone may increase the anticoagulant activities of Mesalazine.,49,Type_49,No
DB00606,Cyclothiazide,DB00796,Candesartan cilexetil,0.4424554705619812,49,Type_49,The risk or severity of adverse effects can be increased when Cyclothiazide is combined with Candesartan cilexetil.,56,Type_56,No
DB01067,Glipizide,DB09280,Lumacaftor,0.41293227672576904,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Glipizide.,75,Type_75,No
DB00570,Vinblastine,DB06145,Spiramycin,0.40166452527046204,73,Type_73,The serum concentration of Spiramycin can be increased when it is combined with Vinblastine.,73,Type_73,Yes
DB00215,Citalopram,DB00541,Vincristine,0.46496230363845825,47,Type_47,The metabolism of Vincristine can be decreased when combined with Citalopram.,73,Type_73,No
DB00312,Pentobarbital,DB00875,Flupentixol,0.40660595893859863,49,Type_49,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Flupentixol.,49,Type_49,Yes
DB01024,Mycophenolic acid,DB01240,Epoprostenol,0.31882697343826294,49,Type_49,The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Epoprostenol.,70,Type_70,No
DB00374,Treprostinil,DB00418,Secobarbital,0.31424492597579956,60,Type_60,Treprostinil may increase the hypotensive activities of Secobarbital.,75,Type_75,No
DB00496,Darifenacin,DB01238,Aripiprazole,0.46038323640823364,73,Type_73,The serum concentration of Aripiprazole can be increased when it is combined with Darifenacin.,73,Type_73,Yes
DB00604,Cisapride,DB00898,Ethanol,0.33753976225852966,47,Type_47,The metabolism of Ethanol can be decreased when combined with Cisapride.,49,Type_49,No
DB00477,Chlorpromazine,DB00976,Telithromycin,0.42396479845046997,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Chlorpromazine.,20,Type_20,No
DB00530,Erlotinib,DB00927,Famotidine,0.4689836800098419,75,Type_75,The serum concentration of Famotidine can be decreased when it is combined with Erlotinib.,75,Type_75,Yes
DB00420,Promazine,DB00934,Maprotiline,0.44268032908439636,49,Type_49,The risk or severity of adverse effects can be increased when Promazine is combined with Maprotiline.,20,Type_20,No
DB01259,Lapatinib,DB08873,Boceprevir,0.48797786235809326,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Lapatinib.,73,Type_73,No
DB00333,Methadone,DB00489,Sotalol,0.43467551469802856,20,Type_20,Methadone may increase the QTc-prolonging activities of Sotalol.,20,Type_20,Yes
DB00679,Thioridazine,DB01576,Dextroamphetamine,0.438124418258667,76,Type_76,Thioridazine may decrease the sedative activities of Dextroamphetamine.,73,Type_73,No
DB01192,Oxymorphone,DB09167,Dosulepin,0.4119246006011963,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Oxymorphone.,47,Type_47,Yes
DB00490,Buspirone,DB01403,Methotrimeprazine,0.49784988164901733,16,Type_16,Buspirone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,16,Type_16,Yes
DB01072,Atazanavir,DB01142,Doxepin,0.4855714440345764,47,Type_47,The metabolism of Doxepin can be decreased when combined with Atazanavir.,75,Type_75,No
DB00396,Progesterone,DB00482,Celecoxib,0.3686694800853729,47,Type_47,The metabolism of Celecoxib can be decreased when combined with Progesterone.,47,Type_47,Yes
DB00404,Alprazolam,DB01124,Tolbutamide,0.42078137397766113,70,Type_70,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Alprazolam.,47,Type_47,No
DB00540,Nortriptyline,DB00622,Nicardipine,0.44248852133750916,20,Type_20,Nortriptyline may increase the QTc-prolonging activities of Nicardipine.,47,Type_47,No
DB00220,Nelfinavir,DB01174,Phenobarbital,0.40961694717407227,4,Type_4,The metabolism of Phenobarbital can be increased when combined with Nelfinavir.,4,Type_4,Yes
DB00458,Imipramine,DB00528,Lercanidipine,0.46444737911224365,49,Type_49,The risk or severity of adverse effects can be increased when Imipramine is combined with Lercanidipine.,49,Type_49,Yes
DB00224,Indinavir,DB08882,Linagliptin,0.4770682156085968,47,Type_47,The metabolism of Linagliptin can be decreased when combined with Indinavir.,75,Type_75,No
DB00604,Cisapride,DB01072,Atazanavir,0.4213366210460663,20,Type_20,Cisapride may increase the QTc-prolonging activities of Atazanavir.,47,Type_47,No
DB00623,Fluphenazine,DB08881,Vemurafenib,0.40040960907936096,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Fluphenazine.,33,Type_33,No
DB00363,Clozapine,DB08882,Linagliptin,0.33245542645454407,70,Type_70,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Clozapine.,70,Type_70,Yes
DB01182,Propafenone,DB09167,Dosulepin,0.49630454182624817,47,Type_47,The metabolism of Dosulepin can be decreased when combined with Propafenone.,73,Type_73,No
DB01240,Epoprostenol,DB06725,Lornoxicam,0.4912627339363098,49,Type_49,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Lornoxicam.,70,Type_70,No
DB00263,Sulfisoxazole,DB06589,Pazopanib,0.3572193682193756,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Sulfisoxazole.,20,Type_20,No
DB00188,Bortezomib,DB00927,Famotidine,0.4557276964187622,47,Type_47,The metabolism of Famotidine can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00396,Progesterone,DB04898,Ximelagatran,0.39510399103164673,75,Type_75,The serum concentration of Ximelagatran can be decreased when it is combined with Progesterone.,70,Type_70,No
DB01001,Salbutamol,DB01200,Bromocriptine,0.3962542712688446,49,Type_49,The risk or severity of adverse effects can be increased when Salbutamol is combined with Bromocriptine.,71,Type_71,No
DB00615,Rifabutin,DB08873,Boceprevir,0.3959308862686157,75,Type_75,The serum concentration of Boceprevir can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB00691,Moexipril,DB06697,Artemether,0.3954351246356964,49,Type_49,The risk or severity of adverse effects can be increased when Moexipril is combined with Artemether.,20,Type_20,No
DB00196,Fluconazole,DB08896,Regorafenib,0.4990881085395813,73,Type_73,The serum concentration of Regorafenib can be increased when it is combined with Fluconazole.,47,Type_47,No
DB01072,Atazanavir,DB06697,Artemether,0.4976826310157776,73,Type_73,The serum concentration of Artemether can be increased when it is combined with Atazanavir.,47,Type_47,No
DB01246,Alimemazine,DB06335,Saxagliptin,0.4291380047798157,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Alimemazine.,75,Type_75,No
DB00277,Theophylline,DB00917,Dinoprostone,0.3702901601791382,75,Type_75,The serum concentration of Dinoprostone can be decreased when it is combined with Theophylline.,47,Type_47,No
DB00679,Thioridazine,DB01577,Metamfetamine,0.3328034579753876,47,Type_47,The metabolism of Metamfetamine can be decreased when combined with Thioridazine.,73,Type_73,No
DB01264,Darunavir,DB12070,Letermovir,0.47647616267204285,73,Type_73,The serum concentration of Letermovir can be increased when it is combined with Darunavir.,73,Type_73,Yes
DB00594,Amiloride,DB09477,Enalaprilat,0.46763876080513,68,Type_68,Amiloride may increase the hyperkalemic activities of Enalaprilat.,68,Type_68,Yes
DB06626,Axitinib,DB09054,Idelalisib,0.4294356405735016,47,Type_47,The metabolism of Idelalisib can be decreased when combined with Axitinib.,73,Type_73,No
DB00433,Prochlorperazine,DB01320,Fosphenytoin,0.4538589119911194,49,Type_49,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Fosphenytoin.,4,Type_4,No
DB00268,Ropinirole,DB00588,Fluticasone propionate,0.47720998525619507,70,Type_70,The therapeutic efficacy of Fluticasone propionate can be decreased when used in combination with Ropinirole.,32,Type_32,No
DB00661,Verapamil,DB01356,Lithium cation,0.4808703362941742,73,Type_73,The serum concentration of Lithium cation can be increased when it is combined with Verapamil.,35,Type_35,No
DB00246,Ziprasidone,DB08907,Canagliflozin,0.48464277386665344,70,Type_70,The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Ziprasidone.,47,Type_47,No
DB01254,Dasatinib,DB05039,Indacaterol,0.47257527709007263,20,Type_20,Dasatinib may increase the QTc-prolonging activities of Indacaterol.,73,Type_73,No
DB00571,Propranolol,DB00953,Rizatriptan,0.3909294903278351,73,Type_73,The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.,73,Type_73,Yes
DB00318,Codeine,DB00363,Clozapine,0.4719263017177582,49,Type_49,The risk or severity of adverse effects can be increased when Codeine is combined with Clozapine.,70,Type_70,No
DB00333,Methadone,DB00691,Moexipril,0.34467628598213196,20,Type_20,Methadone may increase the QTc-prolonging activities of Moexipril.,20,Type_20,Yes
DB00232,Methyclothiazide,DB00898,Ethanol,0.42854222655296326,30,Type_30,Methyclothiazide may increase the orthostatic hypotensive activities of Ethanol.,30,Type_30,Yes
DB00734,Risperidone,DB01580,Oxprenolol,0.47721803188323975,49,Type_49,The risk or severity of adverse effects can be increased when Risperidone is combined with Oxprenolol.,60,Type_60,No
DB00927,Famotidine,DB01211,Clarithromycin,0.399209588766098,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Famotidine.,20,Type_20,No
DB00619,Imatinib,DB00706,Tamsulosin,0.4828766882419586,73,Type_73,The serum concentration of Tamsulosin can be increased when it is combined with Imatinib.,47,Type_47,No
DB01242,Clomipramine,DB01274,Arformoterol,0.40904000401496887,47,Type_47,The metabolism of Arformoterol can be decreased when combined with Clomipramine.,47,Type_47,Yes
DB00450,Droperidol,DB01233,Metoclopramide,0.46353429555892944,49,Type_49,The risk or severity of adverse effects can be increased when Droperidol is combined with Metoclopramide.,49,Type_49,Yes
DB00540,Nortriptyline,DB08880,Teriflunomide,0.4931538999080658,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Nortriptyline.,75,Type_75,Yes
DB00343,Diltiazem,DB00877,Sirolimus,0.48677492141723633,47,Type_47,The metabolism of Sirolimus can be decreased when combined with Diltiazem.,49,Type_49,No
DB00625,Efavirenz,DB06292,Dapagliflozin,0.38797563314437866,4,Type_4,The metabolism of Dapagliflozin can be increased when combined with Efavirenz.,47,Type_47,No
DB00294,Etonogestrel,DB01132,Pioglitazone,0.4815310537815094,70,Type_70,The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Etonogestrel.,70,Type_70,Yes
DB00495,Zidovudine,DB06203,Alogliptin,0.3233639895915985,75,Type_75,The serum concentration of Alogliptin can be decreased when it is combined with Zidovudine.,75,Type_75,Yes
DB00199,Erythromycin,DB01623,Thiothixene,0.40005478262901306,20,Type_20,Erythromycin may increase the QTc-prolonging activities of Thiothixene.,20,Type_20,Yes
DB00571,Propranolol,DB00734,Risperidone,0.3873927891254425,60,Type_60,Propranolol may increase the hypotensive activities of Risperidone.,60,Type_60,Yes
DB00541,Vincristine,DB00705,Delavirdine,0.45434707403182983,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Vincristine.,47,Type_47,Yes
DB01024,Mycophenolic acid,DB01129,Rabeprazole,0.37709900736808777,47,Type_47,The metabolism of Rabeprazole can be decreased when combined with Mycophenolic acid.,75,Type_75,No
DB00864,Tacrolimus,DB01127,Econazole,0.4804571568965912,47,Type_47,The metabolism of Econazole can be decreased when combined with Tacrolimus.,47,Type_47,Yes
DB00417,Phenoxymethylpenicillin,DB00563,Methotrexate,0.3157733678817749,67,Type_67,Phenoxymethylpenicillin can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.,73,Type_73,No
DB01058,Praziquantel,DB01072,Atazanavir,0.4781332015991211,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Praziquantel.,47,Type_47,Yes
DB00455,Loratadine,DB01580,Oxprenolol,0.42891189455986023,49,Type_49,The risk or severity of adverse effects can be increased when Loratadine is combined with Oxprenolol.,49,Type_49,Yes
DB01076,Atorvastatin,DB12598,Nafamostat,0.4920014441013336,49,Type_49,The risk or severity of adverse effects can be increased when Atorvastatin is combined with Nafamostat.,73,Type_73,No
DB01211,Clarithromycin,DB12332,Rucaparib,0.4929885268211365,73,Type_73,The serum concentration of Rucaparib can be increased when it is combined with Clarithromycin.,47,Type_47,No
DB00270,Isradipine,DB00575,Clonidine,0.46633249521255493,47,Type_47,The metabolism of Clonidine can be decreased when combined with Isradipine.,49,Type_49,No
DB00231,Temazepam,DB00238,Nevirapine,0.4434811770915985,47,Type_47,The metabolism of Nevirapine can be decreased when combined with Temazepam.,4,Type_4,No
DB00279,Liothyronine,DB11126,Calcium gluconate,0.4386375844478607,70,Type_70,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Liothyronine.,70,Type_70,Yes
DB00783,Estradiol,DB01319,Fosamprenavir,0.49749013781547546,47,Type_47,The metabolism of Fosamprenavir can be decreased when combined with Estradiol.,75,Type_75,No
DB00924,Cyclobenzaprine,DB01167,Itraconazole,0.4822050631046295,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Cyclobenzaprine.,47,Type_47,Yes
DB00254,Doxycycline,DB00531,Cyclophosphamide,0.4764661192893982,49,Type_49,The risk or severity of adverse effects can be increased when Doxycycline is combined with Cyclophosphamide.,47,Type_47,No
DB00343,Diltiazem,DB01023,Felodipine,0.4566270709037781,47,Type_47,The metabolism of Felodipine can be decreased when combined with Diltiazem.,49,Type_49,No
DB00563,Methotrexate,DB00864,Tacrolimus,0.4330713748931885,49,Type_49,The risk or severity of adverse effects can be increased when Methotrexate is combined with Tacrolimus.,49,Type_49,Yes
DB01104,Sertraline,DB04946,Iloperidone,0.3519948124885559,20,Type_20,Sertraline may increase the QTc-prolonging activities of Iloperidone.,20,Type_20,Yes
DB00255,Diethylstilbestrol,DB00278,Argatroban,0.432417631149292,70,Type_70,The therapeutic efficacy of Argatroban can be decreased when used in combination with Diethylstilbestrol.,75,Type_75,No
DB00983,Formoterol,DB06589,Pazopanib,0.4848053455352783,20,Type_20,Formoterol may increase the QTc-prolonging activities of Pazopanib.,20,Type_20,Yes
DB06203,Alogliptin,DB06414,Etravirine,0.3682921528816223,47,Type_47,The metabolism of Etravirine can be decreased when combined with Alogliptin.,75,Type_75,No
DB01226,Mivacurium,DB04574,Estrone sulfate,0.4053514003753662,22,Type_22,Mivacurium may increase the adverse neuromuscular activities of Estrone sulfate.,22,Type_22,Yes
DB00531,Cyclophosphamide,DB06695,Dabigatran etexilate,0.4866788685321808,77,Type_77,The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Cyclophosphamide.,77,Type_77,Yes
DB00313,Valproic acid,DB00420,Promazine,0.44818317890167236,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Promazine.,49,Type_49,Yes
DB00529,Foscarnet,DB00887,Bumetanide,0.4780323803424835,73,Type_73,The serum concentration of Bumetanide can be increased when it is combined with Foscarnet.,73,Type_73,Yes
DB00470,Dronabinol,DB00619,Imatinib,0.4617202877998352,73,Type_73,The serum concentration of Imatinib can be increased when it is combined with Dronabinol.,73,Type_73,Yes
DB00653,Magnesium sulfate,DB00827,Cinoxacin,0.4942859411239624,49,Type_49,The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Cinoxacin.,75,Type_75,No
DB00270,Isradipine,DB00370,Mirtazapine,0.45137444138526917,37,Type_37,Isradipine may decrease the antihypertensive activities of Mirtazapine.,47,Type_47,No
DB00415,Ampicillin,DB01032,Probenecid,0.41503238677978516,73,Type_73,The serum concentration of Probenecid can be increased when it is combined with Ampicillin.,73,Type_73,Yes
DB00215,Citalopram,DB00374,Treprostinil,0.4284816086292267,20,Type_20,Citalopram may increase the QTc-prolonging activities of Treprostinil.,20,Type_20,Yes
DB00615,Rifabutin,DB09232,Cilnidipine,0.32711148262023926,4,Type_4,The metabolism of Cilnidipine can be increased when combined with Rifabutin.,75,Type_75,No
DB06414,Etravirine,DB08873,Boceprevir,0.4761848747730255,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Etravirine.,75,Type_75,No
DB00420,Promazine,DB01026,Ketoconazole,0.49779847264289856,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Promazine.,47,Type_47,Yes
DB01115,Nifedipine,DB01154,Thiamylal,0.40614742040634155,49,Type_49,The risk or severity of adverse effects can be increased when Nifedipine is combined with Thiamylal.,60,Type_60,No
DB01220,Rifaximin,DB01229,Paclitaxel,0.4154624938964844,4,Type_4,The metabolism of Paclitaxel can be increased when combined with Rifaximin.,73,Type_73,No
DB00252,Phenytoin,DB00623,Fluphenazine,0.36366209387779236,73,Type_73,The serum concentration of Fluphenazine can be increased when it is combined with Phenytoin.,49,Type_49,No
DB01609,Deferasirox,DB06736,Aceclofenac,0.49501433968544006,75,Type_75,The serum concentration of Aceclofenac can be decreased when it is combined with Deferasirox.,49,Type_49,No
DB08922,Perospirone,DB09039,Eliglustat,0.4897426664829254,47,Type_47,The metabolism of Eliglustat can be decreased when combined with Perospirone.,47,Type_47,Yes
DB00696,Ergotamine,DB00714,Apomorphine,0.3267110586166382,25,Type_25,Ergotamine may increase the atrioventricular blocking (AV block) activities of Apomorphine.,19,Type_19,No
DB01072,Atazanavir,DB01259,Lapatinib,0.48133525252342224,73,Type_73,The serum concentration of Lapatinib can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00796,Candesartan cilexetil,DB06414,Etravirine,0.4874666631221771,47,Type_47,The metabolism of Etravirine can be decreased when combined with Candesartan cilexetil.,47,Type_47,Yes
DB00909,Zonisamide,DB06148,Mianserin,0.47500234842300415,70,Type_70,The therapeutic efficacy of Mianserin can be decreased when used in combination with Zonisamide.,70,Type_70,Yes
DB00726,Trimipramine,DB01029,Irbesartan,0.4229919910430908,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Trimipramine.,47,Type_47,Yes
DB00772,Malathion,DB01589,Quazepam,0.44214412569999695,73,Type_73,The serum concentration of Quazepam can be increased when it is combined with Malathion.,73,Type_73,Yes
DB00391,Sulpiride,DB00679,Thioridazine,0.4729197025299072,36,Type_36,Sulpiride may increase the antipsychotic activities of Thioridazine.,36,Type_36,Yes
DB00393,Nimodipine,DB01026,Ketoconazole,0.3969751298427582,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Nimodipine.,73,Type_73,No
DB01076,Atorvastatin,DB01418,Acenocoumarol,0.4064546227455139,49,Type_49,The risk or severity of adverse effects can be increased when Atorvastatin is combined with Acenocoumarol.,6,Type_6,No
DB06201,Rufinamide,DB09118,Stiripentol,0.3968179523944855,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Rufinamide.,49,Type_49,No
DB00489,Sotalol,DB00961,Mepivacaine,0.4719561040401459,49,Type_49,The risk or severity of adverse effects can be increased when Sotalol is combined with Mepivacaine.,73,Type_73,No
DB01156,Bupropion,DB04844,Tetrabenazine,0.4851232171058655,47,Type_47,The metabolism of Tetrabenazine can be decreased when combined with Bupropion.,73,Type_73,No
DB06589,Pazopanib,DB08901,Ponatinib,0.42809975147247314,73,Type_73,The serum concentration of Ponatinib can be increased when it is combined with Pazopanib.,73,Type_73,Yes
DB00582,Voriconazole,DB01251,Gliquidone,0.46061256527900696,70,Type_70,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Voriconazole.,73,Type_73,No
DB00622,Nicardipine,DB08931,Riociguat,0.394163578748703,60,Type_60,Nicardipine may increase the hypotensive activities of Riociguat.,49,Type_49,No
DB00347,Trimethadione,DB05812,Abiraterone,0.4232408404350281,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Trimethadione.,73,Type_73,No
DB00794,Primidone,DB09026,Aliskiren,0.42955905199050903,4,Type_4,The metabolism of Aliskiren can be increased when combined with Primidone.,4,Type_4,Yes
DB00363,Clozapine,DB00708,Sufentanil,0.4858652353286743,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Sufentanil.,49,Type_49,Yes
DB01029,Irbesartan,DB08918,Levomilnacipran,0.33116623759269714,49,Type_49,The risk or severity of adverse effects can be increased when Irbesartan is combined with Levomilnacipran.,47,Type_47,No
DB00818,Propofol,DB00904,Ondansetron,0.4983956515789032,49,Type_49,The risk or severity of adverse effects can be increased when Propofol is combined with Ondansetron.,20,Type_20,No
DB01100,Pimozide,DB08881,Vemurafenib,0.41386649012565613,33,Type_33,The risk or severity of QTc prolongation can be increased when Pimozide is combined with Vemurafenib.,73,Type_73,No
DB01015,Sulfamethoxazole,DB01136,Carvedilol,0.49090883135795593,47,Type_47,The metabolism of Carvedilol can be decreased when combined with Sulfamethoxazole.,73,Type_73,No
DB00207,Azithromycin,DB00946,Phenprocoumon,0.3558485805988312,47,Type_47,The metabolism of Phenprocoumon can be decreased when combined with Azithromycin.,73,Type_73,No
DB00589,Lisuride,DB00624,Testosterone,0.4493521749973297,73,Type_73,The serum concentration of Testosterone can be increased when it is combined with Lisuride.,49,Type_49,No
DB00257,Clotrimazole,DB08903,Bedaquiline,0.4714350700378418,73,Type_73,The serum concentration of Bedaquiline can be increased when it is combined with Clotrimazole.,47,Type_47,No
DB00458,Imipramine,DB00706,Tamsulosin,0.4315660893917084,73,Type_73,The serum concentration of Tamsulosin can be increased when it is combined with Imipramine.,47,Type_47,No
DB01242,Clomipramine,DB09039,Eliglustat,0.43456822633743286,20,Type_20,Clomipramine may increase the QTc-prolonging activities of Eliglustat.,73,Type_73,No
DB00889,Granisetron,DB01591,Solifenacin,0.4516218602657318,20,Type_20,Granisetron may increase the QTc-prolonging activities of Solifenacin.,20,Type_20,Yes
DB00525,Tolnaftate,DB00661,Verapamil,0.49757227301597595,47,Type_47,The metabolism of Verapamil can be decreased when combined with Tolnaftate.,49,Type_49,No
DB00440,Trimethoprim,DB00489,Sotalol,0.4223655164241791,49,Type_49,The risk or severity of adverse effects can be increased when Trimethoprim is combined with Sotalol.,20,Type_20,No
DB01104,Sertraline,DB06626,Axitinib,0.46861201524734497,73,Type_73,The serum concentration of Axitinib can be increased when it is combined with Sertraline.,47,Type_47,No
DB00238,Nevirapine,DB00384,Triamterene,0.4952734708786011,73,Type_73,The serum concentration of Triamterene can be increased when it is combined with Nevirapine.,47,Type_47,No
DB00864,Tacrolimus,DB08882,Linagliptin,0.42376628518104553,73,Type_73,The serum concentration of Linagliptin can be increased when it is combined with Tacrolimus.,75,Type_75,No
DB05812,Abiraterone,DB06148,Mianserin,0.49957889318466187,73,Type_73,The serum concentration of Mianserin can be increased when it is combined with Abiraterone.,73,Type_73,Yes
DB00564,Carbamazepine,DB00999,Hydrochlorothiazide,0.47247475385665894,49,Type_49,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Hydrochlorothiazide.,49,Type_49,Yes
DB01045,Rifampicin,DB09074,Olaparib,0.43542593717575073,75,Type_75,The serum concentration of Olaparib can be decreased when it is combined with Rifampicin.,75,Type_75,Yes
DB00543,Amoxapine,DB01149,Nefazodone,0.3662082850933075,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Nefazodone.,49,Type_49,Yes
DB00810,Biperiden,DB08916,Afatinib,0.3780083656311035,73,Type_73,The serum concentration of Afatinib can be increased when it is combined with Biperiden.,73,Type_73,Yes
DB00543,Amoxapine,DB00599,Thiopental,0.4939801096916199,49,Type_49,The risk or severity of adverse effects can be increased when Amoxapine is combined with Thiopental.,4,Type_4,No
DB00700,Eplerenone,DB00752,Tranylcypromine,0.4838889539241791,49,Type_49,The risk or severity of adverse effects can be increased when Eplerenone is combined with Tranylcypromine.,49,Type_49,Yes
DB00091,Cyclosporine,DB00790,Perindopril,0.41198351979255676,73,Type_73,The serum concentration of Perindopril can be increased when it is combined with Cyclosporine.,73,Type_73,Yes
DB00188,Bortezomib,DB00706,Tamsulosin,0.4538499116897583,47,Type_47,The metabolism of Tamsulosin can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00278,Argatroban,DB00313,Valproic acid,0.33585578203201294,70,Type_70,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Argatroban.,75,Type_75,No
DB00175,Pravastatin,DB01138,Sulfinpyrazone,0.4378880262374878,73,Type_73,The serum concentration of Sulfinpyrazone can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB06210,Eltrombopag,DB11817,Baricitinib,0.48303794860839844,47,Type_47,The metabolism of Baricitinib can be decreased when combined with Eltrombopag.,73,Type_73,No
DB00204,Dofetilide,DB00679,Thioridazine,0.34030574560165405,73,Type_73,The serum concentration of Thioridazine can be increased when it is combined with Dofetilide.,33,Type_33,No
DB00715,Paroxetine,DB06738,Ketobemidone,0.4453890919685364,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Ketobemidone.,47,Type_47,No
DB01424,Aminophenazone,DB08880,Teriflunomide,0.4218376874923706,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Aminophenazone.,75,Type_75,Yes
DB06414,Etravirine,DB06636,Isavuconazonium,0.49177664518356323,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Etravirine.,47,Type_47,Yes
DB00608,Chloroquine,DB01214,Metipranolol,0.43090736865997314,37,Type_37,Chloroquine may decrease the antihypertensive activities of Metipranolol.,47,Type_47,No
DB00489,Sotalol,DB01263,Posaconazole,0.4836636483669281,47,Type_47,The metabolism of Posaconazole can be decreased when combined with Sotalol.,20,Type_20,No
DB01589,Quazepam,DB08873,Boceprevir,0.4858301281929016,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Quazepam.,47,Type_47,No
DB00584,Enalapril,DB06414,Etravirine,0.3289853632450104,75,Type_75,The serum concentration of Etravirine can be decreased when it is combined with Enalapril.,75,Type_75,Yes
DB01058,Praziquantel,DB01211,Clarithromycin,0.46446454524993896,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Praziquantel.,47,Type_47,No
DB00705,Delavirdine,DB01076,Atorvastatin,0.39360272884368896,73,Type_73,The serum concentration of Atorvastatin can be increased when it is combined with Delavirdine.,49,Type_49,No
DB00363,Clozapine,DB00575,Clonidine,0.49311697483062744,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Clonidine.,47,Type_47,No
DB01029,Irbesartan,DB05271,Rotigotine,0.44462886452674866,47,Type_47,The metabolism of Rotigotine can be decreased when combined with Irbesartan.,49,Type_49,No
DB01026,Ketoconazole,DB01264,Darunavir,0.45775243639945984,73,Type_73,The serum concentration of Darunavir can be increased when it is combined with Ketoconazole.,73,Type_73,Yes
DB06414,Etravirine,DB08816,Ticagrelor,0.49721312522888184,47,Type_47,The metabolism of Ticagrelor can be decreased when combined with Etravirine.,47,Type_47,Yes
DB00234,Reboxetine,DB00559,Bosentan,0.49282634258270264,75,Type_75,The serum concentration of Bosentan can be decreased when it is combined with Reboxetine.,75,Type_75,Yes
DB00656,Trazodone,DB04844,Tetrabenazine,0.4979097843170166,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Tetrabenazine.,20,Type_20,No
DB00254,Doxycycline,DB00898,Ethanol,0.37731727957725525,47,Type_47,The metabolism of Ethanol can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00396,Progesterone,DB00997,Doxorubicin,0.4461570978164673,47,Type_47,The metabolism of Doxorubicin can be decreased when combined with Progesterone.,73,Type_73,No
DB00598,Labetalol,DB01158,Bretylium,0.48375508189201355,49,Type_49,The risk or severity of adverse effects can be increased when Labetalol is combined with Bretylium.,54,Type_54,No
DB00753,Isoflurane,DB01242,Clomipramine,0.4263555705547333,47,Type_47,The metabolism of Clomipramine can be decreased when combined with Isoflurane.,49,Type_49,No
DB00193,Tramadol,DB06016,Cariprazine,0.4879145324230194,47,Type_47,The metabolism of Cariprazine can be decreased when combined with Tramadol.,49,Type_49,No
DB04855,Dronedarone,DB08815,Lurasidone,0.4541727900505066,73,Type_73,The serum concentration of Lurasidone can be increased when it is combined with Dronedarone.,73,Type_73,Yes
DB00653,Magnesium sulfate,DB00758,Clopidogrel,0.40805938839912415,47,Type_47,The metabolism of Clopidogrel can be decreased when combined with Magnesium sulfate.,70,Type_70,No
DB01087,Primaquine,DB06697,Artemether,0.3288588523864746,33,Type_33,The risk or severity of QTc prolongation can be increased when Primaquine is combined with Artemether.,33,Type_33,Yes
DB01018,Guanfacine,DB01124,Tolbutamide,0.30233100056648254,47,Type_47,The metabolism of Tolbutamide can be decreased when combined with Guanfacine.,47,Type_47,Yes
DB01036,Tolterodine,DB01264,Darunavir,0.4923163652420044,47,Type_47,The metabolism of Darunavir can be decreased when combined with Tolterodine.,73,Type_73,No
DB01054,Nitrendipine,DB01154,Thiamylal,0.45146146416664124,4,Type_4,The metabolism of Thiamylal can be increased when combined with Nitrendipine.,4,Type_4,Yes
DB00476,Duloxetine,DB00726,Trimipramine,0.44647082686424255,49,Type_49,The risk or severity of adverse effects can be increased when Duloxetine is combined with Trimipramine.,64,Type_64,No
DB00731,Nateglinide,DB00864,Tacrolimus,0.4511260688304901,34,Type_34,Nateglinide may increase the immunosuppressive activities of Tacrolimus.,70,Type_70,No
DB00679,Thioridazine,DB09204,Arotinolol,0.4298493564128876,49,Type_49,The risk or severity of adverse effects can be increased when Thioridazine is combined with Arotinolol.,60,Type_60,No
DB00235,Milrinone,DB00936,Salicylic acid,0.40919315814971924,70,Type_70,The therapeutic efficacy of Salicylic acid can be decreased when used in combination with Milrinone.,49,Type_49,No
DB00749,Etodolac,DB00936,Salicylic acid,0.4967895746231079,57,Type_57,Etodolac may increase the nephrotoxic activities of Salicylic acid.,49,Type_49,No
DB00849,Methylphenobarbital,DB09236,Lacidipine,0.4515034854412079,49,Type_49,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Lacidipine.,4,Type_4,No
DB00962,Zaleplon,DB01264,Darunavir,0.416765034198761,47,Type_47,The metabolism of Darunavir can be decreased when combined with Zaleplon.,47,Type_47,Yes
DB04574,Estrone sulfate,DB09070,Tibolone,0.32928162813186646,75,Type_75,The serum concentration of Tibolone can be decreased when it is combined with Estrone sulfate.,73,Type_73,No
DB01229,Paclitaxel,DB01355,Hexobarbital,0.4634099006652832,47,Type_47,The metabolism of Hexobarbital can be decreased when combined with Paclitaxel.,60,Type_60,No
DB00575,Clonidine,DB00976,Telithromycin,0.365469366312027,20,Type_20,Clonidine may increase the QTc-prolonging activities of Telithromycin.,47,Type_47,No
DB00227,Lovastatin,DB01253,Ergometrine,0.36365795135498047,47,Type_47,The metabolism of Ergometrine can be decreased when combined with Lovastatin.,47,Type_47,Yes
DB00196,Fluconazole,DB00927,Famotidine,0.45395520329475403,47,Type_47,The metabolism of Famotidine can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB01132,Pioglitazone,DB04839,Cyproterone acetate,0.3655102252960205,73,Type_73,The serum concentration of Cyproterone acetate can be increased when it is combined with Pioglitazone.,70,Type_70,No
DB00502,Haloperidol,DB01142,Doxepin,0.4790458381175995,20,Type_20,Haloperidol may increase the QTc-prolonging activities of Doxepin.,20,Type_20,Yes
DB00598,Labetalol,DB01118,Amiodarone,0.4167073965072632,54,Type_54,Labetalol may increase the bradycardic activities of Amiodarone.,54,Type_54,Yes
DB00294,Etonogestrel,DB00834,Mifepristone,0.4368704557418823,75,Type_75,The serum concentration of Mifepristone can be decreased when it is combined with Etonogestrel.,73,Type_73,No
DB00875,Flupentixol,DB06589,Pazopanib,0.46821388602256775,73,Type_73,The serum concentration of Pazopanib can be increased when it is combined with Flupentixol.,73,Type_73,Yes
DB00482,Celecoxib,DB00519,Trandolapril,0.41744115948677063,49,Type_49,The risk or severity of adverse effects can be increased when Celecoxib is combined with Trandolapril.,49,Type_49,Yes
DB00492,Fosinopril,DB13595,Almasilate,0.4819902181625366,75,Type_75,The serum concentration of Almasilate can be decreased when it is combined with Fosinopril.,75,Type_75,Yes
DB00783,Estradiol,DB00974,Edetic acid,0.46555647253990173,70,Type_70,The therapeutic efficacy of Edetic acid can be decreased when used in combination with Estradiol.,12,Type_12,No
DB00731,Nateglinide,DB06335,Saxagliptin,0.4705096185207367,70,Type_70,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Nateglinide.,9,Type_9,No
DB00224,Indinavir,DB06335,Saxagliptin,0.4321860373020172,47,Type_47,The metabolism of Saxagliptin can be decreased when combined with Indinavir.,73,Type_73,No
DB01076,Atorvastatin,DB06636,Isavuconazonium,0.43801236152648926,73,Type_73,The serum concentration of Isavuconazonium can be increased when it is combined with Atorvastatin.,49,Type_49,No
DB09118,Stiripentol,DB13158,Clobetasone,0.48137032985687256,75,Type_75,The serum concentration of Clobetasone can be decreased when it is combined with Stiripentol.,73,Type_73,No
DB01355,Hexobarbital,DB09235,Efonidipine,0.4251953661441803,49,Type_49,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Efonidipine.,4,Type_4,No
DB00196,Fluconazole,DB01320,Fosphenytoin,0.49265962839126587,73,Type_73,The serum concentration of Fosphenytoin can be increased when it is combined with Fluconazole.,73,Type_73,Yes
DB01167,Itraconazole,DB08883,Perampanel,0.48515620827674866,73,Type_73,The serum concentration of Perampanel can be increased when it is combined with Itraconazole.,47,Type_47,No
DB00238,Nevirapine,DB04835,Maraviroc,0.4731423258781433,47,Type_47,The metabolism of Maraviroc can be decreased when combined with Nevirapine.,75,Type_75,No
DB00794,Primidone,DB00875,Flupentixol,0.4395756721496582,75,Type_75,The serum concentration of Flupentixol can be decreased when it is combined with Primidone.,49,Type_49,No
DB06589,Pazopanib,DB06636,Isavuconazonium,0.46936091780662537,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Pazopanib.,73,Type_73,No
DB00625,Efavirenz,DB01264,Darunavir,0.4857916831970215,47,Type_47,The metabolism of Darunavir can be decreased when combined with Efavirenz.,73,Type_73,No
DB00224,Indinavir,DB01195,Flecainide,0.48132428526878357,73,Type_73,The serum concentration of Flecainide can be increased when it is combined with Indinavir.,47,Type_47,No
DB01201,Rifapentine,DB09230,Azelnidipine,0.4981105923652649,75,Type_75,The serum concentration of Azelnidipine can be decreased when it is combined with Rifapentine.,75,Type_75,Yes
DB00589,Lisuride,DB00951,Isoniazid,0.4286419451236725,49,Type_49,The risk or severity of adverse effects can be increased when Lisuride is combined with Isoniazid.,47,Type_47,No
DB00540,Nortriptyline,DB09280,Lumacaftor,0.47470623254776,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Nortriptyline.,75,Type_75,Yes
DB01196,Estramustine,DB06695,Dabigatran etexilate,0.31747177243232727,75,Type_75,The serum concentration of Dabigatran etexilate can be decreased when it is combined with Estramustine.,77,Type_77,No
DB00320,Dihydroergotamine,DB01229,Paclitaxel,0.49204716086387634,47,Type_47,The metabolism of Paclitaxel can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB00683,Midazolam,DB01197,Captopril,0.3947034180164337,47,Type_47,The metabolism of Captopril can be decreased when combined with Midazolam.,73,Type_73,No
DB00364,Sucralfate,DB00936,Salicylic acid,0.4657513201236725,75,Type_75,The serum concentration of Salicylic acid can be decreased when it is combined with Sucralfate.,67,Type_67,No
DB00367,Levonorgestrel,DB00569,Fondaparinux,0.43381425738334656,12,Type_12,Levonorgestrel may decrease the anticoagulant activities of Fondaparinux.,70,Type_70,No
DB01466,Ethylmorphine,DB09118,Stiripentol,0.434759259223938,73,Type_73,The serum concentration of Stiripentol can be increased when it is combined with Ethylmorphine.,73,Type_73,Yes
DB00748,Carbinoxamine,DB09280,Lumacaftor,0.39028865098953247,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Carbinoxamine.,73,Type_73,No
DB00656,Trazodone,DB00680,Moricizine,0.3942677676677704,49,Type_49,The risk or severity of adverse effects can be increased when Trazodone is combined with Moricizine.,49,Type_49,Yes
DB00691,Moexipril,DB00705,Delavirdine,0.309862345457077,47,Type_47,The metabolism of Delavirdine can be decreased when combined with Moexipril.,75,Type_75,No
DB00320,Dihydroergotamine,DB01200,Bromocriptine,0.281630277633667,19,Type_19,Dihydroergotamine may increase the vasoconstricting activities of Bromocriptine.,49,Type_49,No
DB00006,Bivalirudin,DB00864,Tacrolimus,0.41075074672698975,73,Type_73,The serum concentration of Tacrolimus can be increased when it is combined with Bivalirudin.,47,Type_47,No
DB00203,Sildenafil,DB00346,Alfuzosin,0.4327082335948944,10,Type_10,Sildenafil may increase the antihypertensive activities of Alfuzosin.,60,Type_60,No
DB00877,Sirolimus,DB01120,Gliclazide,0.45758238434791565,70,Type_70,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Sirolimus.,70,Type_70,Yes
DB00175,Pravastatin,DB00877,Sirolimus,0.3710479438304901,73,Type_73,The serum concentration of Sirolimus can be increased when it is combined with Pravastatin.,73,Type_73,Yes
DB01132,Pioglitazone,DB06702,Fesoterodine,0.4946017563343048,77,Type_77,The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Pioglitazone.,77,Type_77,Yes
DB01174,Phenobarbital,DB09231,Benidipine,0.41740530729293823,4,Type_4,The metabolism of Benidipine can be increased when combined with Phenobarbital.,4,Type_4,Yes
DB01184,Domperidone,DB08880,Teriflunomide,0.41578975319862366,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Domperidone.,75,Type_75,No
DB00182,Amphetamine,DB01171,Moclobemide,0.4442932605743408,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Moclobemide.,49,Type_49,Yes
DB01100,Pimozide,DB04868,Nilotinib,0.4381953179836273,20,Type_20,Pimozide may increase the QTc-prolonging activities of Nilotinib.,73,Type_73,No
DB00320,Dihydroergotamine,DB08907,Canagliflozin,0.47582384943962097,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Canagliflozin.,47,Type_47,No
DB00420,Promazine,DB08865,Crizotinib,0.45978978276252747,20,Type_20,Promazine may increase the QTc-prolonging activities of Crizotinib.,20,Type_20,Yes
DB01580,Oxprenolol,DB08910,Pomalidomide,0.4472482204437256,49,Type_49,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Pomalidomide.,49,Type_49,Yes
DB04573,Estriol,DB08439,Parecoxib,0.48290887475013733,73,Type_73,The serum concentration of Parecoxib can be increased when it is combined with Estriol.,81,Type_81,No
DB00285,Venlafaxine,DB04948,Lofexidine,0.4544457495212555,85,Type_85,Venlafaxine may increase the tachycardic activities of Lofexidine.,85,Type_85,Yes
DB00514,Dextromethorphan,DB01624,Zuclopenthixol,0.47938594222068787,49,Type_49,The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Zuclopenthixol.,49,Type_49,Yes
DB00951,Isoniazid,DB01238,Aripiprazole,0.4868145287036896,75,Type_75,The serum concentration of Aripiprazole can be decreased when it is combined with Isoniazid.,73,Type_73,No
DB01012,Cinacalcet,DB09065,Cobicistat,0.4688396155834198,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Cinacalcet.,47,Type_47,No
DB00604,Cisapride,DB01026,Ketoconazole,0.4932976961135864,20,Type_20,Cisapride may increase the QTc-prolonging activities of Ketoconazole.,73,Type_73,No
DB01254,Dasatinib,DB06403,Ambrisentan,0.41059550642967224,73,Type_73,The serum concentration of Ambrisentan can be increased when it is combined with Dasatinib.,73,Type_73,Yes
DB01167,Itraconazole,DB06694,Xylometazoline,0.4955741763114929,49,Type_49,The risk or severity of adverse effects can be increased when Itraconazole is combined with Xylometazoline.,49,Type_49,Yes
DB00281,Lidocaine,DB00349,Clobazam,0.45267611742019653,47,Type_47,The metabolism of Clobazam can be decreased when combined with Lidocaine.,47,Type_47,Yes
DB00448,Lansoprazole,DB00615,Rifabutin,0.4693753719329834,75,Type_75,The serum concentration of Rifabutin can be decreased when it is combined with Lansoprazole.,4,Type_4,No
DB00418,Secobarbital,DB09570,Ixazomib,0.38247397541999817,4,Type_4,The metabolism of Ixazomib can be increased when combined with Secobarbital.,4,Type_4,Yes
DB01656,Roflumilast,DB06772,Cabazitaxel,0.42601388692855835,4,Type_4,The metabolism of Cabazitaxel can be increased when combined with Roflumilast.,34,Type_34,No
DB00890,Dienestrol,DB00949,Felbamate,0.3812405467033386,70,Type_70,The therapeutic efficacy of Felbamate can be decreased when used in combination with Dienestrol.,75,Type_75,No
DB01179,Podofilox,DB09280,Lumacaftor,0.4935370087623596,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Podofilox.,75,Type_75,Yes
DB01095,Fluvastatin,DB06712,Nilvadipine,0.4574452042579651,73,Type_73,The serum concentration of Nilvadipine can be increased when it is combined with Fluvastatin.,73,Type_73,Yes
DB00472,Fluoxetine,DB00960,Pindolol,0.4284290373325348,47,Type_47,The metabolism of Pindolol can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB01320,Fosphenytoin,DB06287,Temsirolimus,0.48861488699913025,75,Type_75,The serum concentration of Temsirolimus can be decreased when it is combined with Fosphenytoin.,75,Type_75,Yes
DB00252,Phenytoin,DB09065,Cobicistat,0.4641111195087433,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Phenytoin.,75,Type_75,No
DB00598,Labetalol,DB01151,Desipramine,0.42489105463027954,47,Type_47,The metabolism of Desipramine can be decreased when combined with Labetalol.,47,Type_47,Yes
DB00243,Ranolazine,DB08816,Ticagrelor,0.3772604763507843,73,Type_73,The serum concentration of Ticagrelor can be increased when it is combined with Ranolazine.,73,Type_73,Yes
DB00641,Simvastatin,DB00921,Buprenorphine,0.49059411883354187,73,Type_73,The serum concentration of Buprenorphine can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00672,Chlorpropamide,DB05812,Abiraterone,0.49973633885383606,47,Type_47,The metabolism of Abiraterone can be decreased when combined with Chlorpropamide.,47,Type_47,Yes
DB00333,Methadone,DB00933,Mesoridazine,0.4904695153236389,49,Type_49,The risk or severity of adverse effects can be increased when Methadone is combined with Mesoridazine.,47,Type_47,No
DB00752,Tranylcypromine,DB00983,Formoterol,0.4961341321468353,49,Type_49,The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Formoterol.,47,Type_47,No
DB00625,Efavirenz,DB01580,Oxprenolol,0.36427101492881775,73,Type_73,The serum concentration of Oxprenolol can be increased when it is combined with Efavirenz.,49,Type_49,No
DB00752,Tranylcypromine,DB00889,Granisetron,0.4811716079711914,64,Type_64,Tranylcypromine may increase the serotonergic activities of Granisetron.,64,Type_64,Yes
DB01043,Memantine,DB09275,Bismuth subcitrate potassium,0.4778922498226166,73,Type_73,The serum concentration of Bismuth subcitrate potassium can be increased when it is combined with Memantine.,73,Type_73,Yes
DB00661,Verapamil,DB09026,Aliskiren,0.4498468339443207,47,Type_47,The metabolism of Aliskiren can be decreased when combined with Verapamil.,73,Type_73,No
DB00188,Bortezomib,DB00196,Fluconazole,0.34707239270210266,47,Type_47,The metabolism of Fluconazole can be decreased when combined with Bortezomib.,47,Type_47,Yes
DB00270,Isradipine,DB01193,Acebutolol,0.48871538043022156,47,Type_47,The metabolism of Acebutolol can be decreased when combined with Isradipine.,49,Type_49,No
DB00320,Dihydroergotamine,DB01220,Rifaximin,0.42700251936912537,47,Type_47,The metabolism of Rifaximin can be decreased when combined with Dihydroergotamine.,73,Type_73,No
DB00615,Rifabutin,DB01058,Praziquantel,0.3701780140399933,75,Type_75,The serum concentration of Praziquantel can be decreased when it is combined with Rifabutin.,75,Type_75,Yes
DB01431,Allylestrenol,DB12598,Nafamostat,0.4719640016555786,70,Type_70,The therapeutic efficacy of Nafamostat can be decreased when used in combination with Allylestrenol.,70,Type_70,Yes
DB00818,Propofol,DB01193,Acebutolol,0.3647673428058624,47,Type_47,The metabolism of Acebutolol can be decreased when combined with Propofol.,49,Type_49,No
DB00549,Zafirlukast,DB00589,Lisuride,0.4367501139640808,47,Type_47,The metabolism of Lisuride can be decreased when combined with Zafirlukast.,49,Type_49,No
DB00264,Metoprolol,DB01118,Amiodarone,0.4447389841079712,47,Type_47,The metabolism of Amiodarone can be decreased when combined with Metoprolol.,73,Type_73,No
DB08873,Boceprevir,DB09227,Barnidipine,0.38232263922691345,47,Type_47,The metabolism of Barnidipine can be decreased when combined with Boceprevir.,73,Type_73,No
DB01087,Primaquine,DB01396,Digitoxin,0.348667711019516,73,Type_73,The serum concentration of Digitoxin can be increased when it is combined with Primaquine.,73,Type_73,Yes
DB00421,Spironolactone,DB00594,Amiloride,0.4764649271965027,68,Type_68,Spironolactone may increase the hyperkalemic activities of Amiloride.,68,Type_68,Yes
DB00220,Nelfinavir,DB00625,Efavirenz,0.41233938932418823,73,Type_73,The serum concentration of Efavirenz can be increased when it is combined with Nelfinavir.,47,Type_47,No
DB00412,Rosiglitazone,DB06605,Apixaban,0.36815112829208374,6,Type_6,Rosiglitazone may increase the anticoagulant activities of Apixaban.,6,Type_6,Yes
DB00715,Paroxetine,DB01233,Metoclopramide,0.4463505744934082,49,Type_49,The risk or severity of adverse effects can be increased when Paroxetine is combined with Metoclopramide.,49,Type_49,Yes
DB00653,Magnesium sulfate,DB01026,Ketoconazole,0.4555767774581909,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Magnesium sulfate.,49,Type_49,No
DB00396,Progesterone,DB01418,Acenocoumarol,0.43363696336746216,73,Type_73,The serum concentration of Acenocoumarol can be increased when it is combined with Progesterone.,70,Type_70,No
DB00196,Fluconazole,DB01232,Saquinavir,0.44778141379356384,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Fluconazole.,20,Type_20,No
DB00862,Vardenafil,DB08881,Vemurafenib,0.3779270648956299,73,Type_73,The serum concentration of Vemurafenib can be increased when it is combined with Vardenafil.,75,Type_75,No
DB00568,Cinnarizine,DB00852,Pseudoephedrine,0.3500136733055115,76,Type_76,Cinnarizine may decrease the sedative activities of Pseudoephedrine.,76,Type_76,Yes
DB00914,Phenformin,DB01232,Saquinavir,0.49189111590385437,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Phenformin.,70,Type_70,No
DB00279,Liothyronine,DB09070,Tibolone,0.4314347207546234,70,Type_70,The therapeutic efficacy of Tibolone can be decreased when used in combination with Liothyronine.,70,Type_70,Yes
DB00834,Mifepristone,DB01045,Rifampicin,0.4381599724292755,75,Type_75,The serum concentration of Rifampicin can be decreased when it is combined with Mifepristone.,73,Type_73,No
DB00238,Nevirapine,DB12001,Abemaciclib,0.3461586534976959,47,Type_47,The metabolism of Abemaciclib can be decreased when combined with Nevirapine.,75,Type_75,No
DB00252,Phenytoin,DB00865,Benzphetamine,0.40504005551338196,70,Type_70,The therapeutic efficacy of Benzphetamine can be decreased when used in combination with Phenytoin.,75,Type_75,No
DB00564,Carbamazepine,DB01406,Danazol,0.46185019612312317,75,Type_75,The serum concentration of Danazol can be decreased when it is combined with Carbamazepine.,47,Type_47,No
DB00252,Phenytoin,DB01614,Acepromazine,0.47360894083976746,49,Type_49,The risk or severity of adverse effects can be increased when Phenytoin is combined with Acepromazine.,49,Type_49,Yes
DB00529,Foscarnet,DB00694,Daunorubicin,0.4864458441734314,57,Type_57,Foscarnet may increase the nephrotoxic activities of Daunorubicin.,57,Type_57,Yes
DB00655,Estrone,DB00932,Tipranavir,0.39388272166252136,73,Type_73,The serum concentration of Tipranavir can be increased when it is combined with Estrone.,28,Type_28,No
DB00204,Dofetilide,DB00458,Imipramine,0.41602274775505066,20,Type_20,Dofetilide may increase the QTc-prolonging activities of Imipramine.,20,Type_20,Yes
DB01075,Diphenhydramine,DB01142,Doxepin,0.38881295919418335,49,Type_49,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Doxepin.,47,Type_47,No
DB00193,Tramadol,DB00283,Clemastine,0.4125804901123047,16,Type_16,Tramadol may increase the central nervous system depressant (CNS depressant) activities of Clemastine.,70,Type_70,No
DB00243,Ranolazine,DB00400,Griseofulvin,0.4836382567882538,47,Type_47,The metabolism of Griseofulvin can be decreased when combined with Ranolazine.,73,Type_73,No
DB00495,Zidovudine,DB06605,Apixaban,0.3891862630844116,75,Type_75,The serum concentration of Apixaban can be decreased when it is combined with Zidovudine.,75,Type_75,Yes
DB00983,Formoterol,DB01232,Saquinavir,0.3502761423587799,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Formoterol.,20,Type_20,No
DB00177,Valsartan,DB01193,Acebutolol,0.44332781434059143,49,Type_49,The risk or severity of adverse effects can be increased when Valsartan is combined with Acebutolol.,49,Type_49,Yes
DB01037,Selegiline,DB08873,Boceprevir,0.4432772994041443,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Selegiline.,47,Type_47,No
DB00207,Azithromycin,DB00315,Zolmitriptan,0.49634647369384766,47,Type_47,The metabolism of Zolmitriptan can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB00810,Biperiden,DB09075,Edoxaban,0.3571321964263916,12,Type_12,Biperiden may decrease the anticoagulant activities of Edoxaban.,73,Type_73,No
DB00599,Thiopental,DB01220,Rifaximin,0.4491525888442993,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Thiopental.,4,Type_4,No
DB00678,Losartan,DB01037,Selegiline,0.42820534110069275,60,Type_60,Losartan may increase the hypotensive activities of Selegiline.,49,Type_49,No
DB00976,Telithromycin,DB01591,Solifenacin,0.49512243270874023,47,Type_47,The metabolism of Solifenacin can be decreased when combined with Telithromycin.,47,Type_47,Yes
DB00951,Isoniazid,DB11921,Deflazacort,0.49322912096977234,47,Type_47,The metabolism of Deflazacort can be decreased when combined with Isoniazid.,75,Type_75,No
DB01193,Acebutolol,DB08931,Riociguat,0.46223849058151245,49,Type_49,The risk or severity of adverse effects can be increased when Acebutolol is combined with Riociguat.,49,Type_49,Yes
DB00625,Efavirenz,DB00752,Tranylcypromine,0.33149972558021545,49,Type_49,The risk or severity of adverse effects can be increased when Efavirenz is combined with Tranylcypromine.,49,Type_49,Yes
DB01200,Bromocriptine,DB01626,Pargyline,0.4295137822628021,47,Type_47,The metabolism of Pargyline can be decreased when combined with Bromocriptine.,9,Type_9,No
DB00321,Amitriptyline,DB00675,Tamoxifen,0.40789350867271423,20,Type_20,Amitriptyline may increase the QTc-prolonging activities of Tamoxifen.,47,Type_47,No
DB00204,Dofetilide,DB01151,Desipramine,0.3813542425632477,73,Type_73,The serum concentration of Desipramine can be increased when it is combined with Dofetilide.,20,Type_20,No
DB01166,Cilostazol,DB06636,Isavuconazonium,0.3910660743713379,47,Type_47,The metabolism of Isavuconazonium can be decreased when combined with Cilostazol.,73,Type_73,No
DB00607,Nafcillin,DB00661,Verapamil,0.3297172784805298,73,Type_73,The serum concentration of Verapamil can be increased when it is combined with Nafcillin.,4,Type_4,No
DB01138,Sulfinpyrazone,DB08880,Teriflunomide,0.4669392704963684,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Sulfinpyrazone.,47,Type_47,No
DB00373,Timolol,DB05812,Abiraterone,0.476811945438385,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Timolol.,73,Type_73,Yes
DB01214,Metipranolol,DB01242,Clomipramine,0.4541339576244354,73,Type_73,The serum concentration of Clomipramine can be increased when it is combined with Metipranolol.,49,Type_49,No
DB00320,Dihydroergotamine,DB06684,Vilazodone,0.4971226751804352,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Vilazodone.,73,Type_73,No
DB00358,Mefloquine,DB00997,Doxorubicin,0.4006543457508087,73,Type_73,The serum concentration of Doxorubicin can be increased when it is combined with Mefloquine.,73,Type_73,Yes
DB00691,Moexipril,DB01601,Lopinavir,0.37010836601257324,20,Type_20,Moexipril may increase the QTc-prolonging activities of Lopinavir.,20,Type_20,Yes
DB00440,Trimethoprim,DB00700,Eplerenone,0.48249951004981995,68,Type_68,Trimethoprim may increase the hyperkalemic activities of Eplerenone.,68,Type_68,Yes
DB00244,Mesalazine,DB08880,Teriflunomide,0.41167324781417847,49,Type_49,The risk or severity of adverse effects can be increased when Mesalazine is combined with Teriflunomide.,57,Type_57,No
DB01253,Ergometrine,DB06616,Bosutinib,0.43166473507881165,73,Type_73,The serum concentration of Bosutinib can be increased when it is combined with Ergometrine.,73,Type_73,Yes
DB00238,Nevirapine,DB00864,Tacrolimus,0.39556217193603516,47,Type_47,The metabolism of Tacrolimus can be decreased when combined with Nevirapine.,4,Type_4,No
DB00363,Clozapine,DB08868,Fingolimod,0.4944905638694763,47,Type_47,The metabolism of Fingolimod can be decreased when combined with Clozapine.,20,Type_20,No
DB00951,Isoniazid,DB01071,Mequitazine,0.4396167993545532,75,Type_75,The serum concentration of Mequitazine can be decreased when it is combined with Isoniazid.,47,Type_47,No
DB00195,Betaxolol,DB00396,Progesterone,0.48815301060676575,47,Type_47,The metabolism of Progesterone can be decreased when combined with Betaxolol.,47,Type_47,Yes
DB00199,Erythromycin,DB00726,Trimipramine,0.4593316316604614,47,Type_47,The metabolism of Trimipramine can be decreased when combined with Erythromycin.,20,Type_20,No
DB00343,Diltiazem,DB09280,Lumacaftor,0.4168572723865509,4,Type_4,The metabolism of Lumacaftor can be increased when combined with Diltiazem.,73,Type_73,No
DB00783,Estradiol,DB11586,Asunaprevir,0.4592609405517578,70,Type_70,The therapeutic efficacy of Asunaprevir can be decreased when used in combination with Estradiol.,75,Type_75,No
DB01200,Bromocriptine,DB06216,Asenapine,0.4917348027229309,73,Type_73,The serum concentration of Asenapine can be increased when it is combined with Bromocriptine.,70,Type_70,No
DB00603,Medroxyprogesterone acetate,DB01211,Clarithromycin,0.45579445362091064,47,Type_47,The metabolism of Clarithromycin can be decreased when combined with Medroxyprogesterone acetate.,73,Type_73,No
DB01137,Levofloxacin,DB06697,Artemether,0.433016836643219,20,Type_20,Levofloxacin may increase the QTc-prolonging activities of Artemether.,20,Type_20,Yes
DB00788,Naproxen,DB01097,Leflunomide,0.4452120065689087,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Naproxen.,47,Type_47,Yes
DB00254,Doxycycline,DB00808,Indapamide,0.4587756395339966,47,Type_47,The metabolism of Indapamide can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00568,Cinnarizine,DB09280,Lumacaftor,0.43662503361701965,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Cinnarizine.,75,Type_75,Yes
DB00281,Lidocaine,DB01182,Propafenone,0.464742511510849,73,Type_73,The serum concentration of Propafenone can be increased when it is combined with Lidocaine.,47,Type_47,No
DB00541,Vincristine,DB01110,Miconazole,0.3964667022228241,73,Type_73,The serum concentration of Miconazole can be increased when it is combined with Vincristine.,73,Type_73,Yes
DB00373,Timolol,DB01224,Quetiapine,0.34190064668655396,49,Type_49,The risk or severity of adverse effects can be increased when Timolol is combined with Quetiapine.,49,Type_49,Yes
DB00349,Clobazam,DB00433,Prochlorperazine,0.4688069820404053,47,Type_47,The metabolism of Prochlorperazine can be decreased when combined with Clobazam.,47,Type_47,Yes
DB00283,Clemastine,DB01045,Rifampicin,0.3724396228790283,47,Type_47,The metabolism of Rifampicin can be decreased when combined with Clemastine.,47,Type_47,Yes
DB00615,Rifabutin,DB09065,Cobicistat,0.3870006799697876,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Rifabutin.,47,Type_47,No
DB00313,Valproic acid,DB01075,Diphenhydramine,0.44769370555877686,47,Type_47,The metabolism of Diphenhydramine can be decreased when combined with Valproic acid.,49,Type_49,No
DB00625,Efavirenz,DB00976,Telithromycin,0.4626016914844513,47,Type_47,The metabolism of Telithromycin can be decreased when combined with Efavirenz.,47,Type_47,Yes
DB01100,Pimozide,DB01151,Desipramine,0.37425926327705383,20,Type_20,Pimozide may increase the QTc-prolonging activities of Desipramine.,20,Type_20,Yes
DB00320,Dihydroergotamine,DB00790,Perindopril,0.43831896781921387,73,Type_73,The serum concentration of Perindopril can be increased when it is combined with Dihydroergotamine.,73,Type_73,Yes
DB01014,Balsalazide,DB01033,Mercaptopurine,0.462738573551178,47,Type_47,The metabolism of Mercaptopurine can be decreased when combined with Balsalazide.,47,Type_47,Yes
DB00508,Triflupromazine,DB01131,Proguanil,0.4779176712036133,47,Type_47,The metabolism of Proguanil can be decreased when combined with Triflupromazine.,73,Type_73,No
DB00398,Sorafenib,DB00762,Irinotecan,0.4727509915828705,73,Type_73,The serum concentration of Irinotecan can be increased when it is combined with Sorafenib.,73,Type_73,Yes
DB00321,Amitriptyline,DB01023,Felodipine,0.40599945187568665,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Felodipine.,47,Type_47,No
DB00204,Dofetilide,DB00370,Mirtazapine,0.4192981421947479,20,Type_20,Dofetilide may increase the QTc-prolonging activities of Mirtazapine.,20,Type_20,Yes
DB00196,Fluconazole,DB00503,Ritonavir,0.44236087799072266,47,Type_47,The metabolism of Ritonavir can be decreased when combined with Fluconazole.,47,Type_47,Yes
DB00207,Azithromycin,DB01211,Clarithromycin,0.3927310109138489,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Azithromycin.,20,Type_20,No
DB00454,Meperidine,DB01149,Nefazodone,0.44596272706985474,64,Type_64,Meperidine may increase the serotonergic activities of Nefazodone.,47,Type_47,No
DB00794,Primidone,DB01325,Quinethazone,0.4574730694293976,30,Type_30,Primidone may increase the orthostatic hypotensive activities of Quinethazone.,30,Type_30,Yes
DB00257,Clotrimazole,DB00531,Cyclophosphamide,0.4722539782524109,47,Type_47,The metabolism of Cyclophosphamide can be decreased when combined with Clotrimazole.,47,Type_47,Yes
DB00655,Estrone,DB01059,Norfloxacin,0.3073115944862366,49,Type_49,The risk or severity of adverse effects can be increased when Estrone is combined with Norfloxacin.,49,Type_49,Yes
DB00193,Tramadol,DB08864,Rilpivirine,0.49402227997779846,73,Type_73,The serum concentration of Rilpivirine can be increased when it is combined with Tramadol.,75,Type_75,No
DB06724,Calcium carbonate,DB08931,Riociguat,0.48802265524864197,75,Type_75,The serum concentration of Riociguat can be decreased when it is combined with Calcium carbonate.,75,Type_75,Yes
DB00285,Venlafaxine,DB00934,Maprotiline,0.4426650404930115,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Maprotiline.,49,Type_49,Yes
DB01074,Perhexiline,DB01589,Quazepam,0.43024367094039917,47,Type_47,The metabolism of Quazepam can be decreased when combined with Perhexiline.,73,Type_73,No
DB00006,Bivalirudin,DB06414,Etravirine,0.4134521782398224,47,Type_47,The metabolism of Etravirine can be decreased when combined with Bivalirudin.,75,Type_75,No
DB00261,Anagrelide,DB01211,Clarithromycin,0.3885681927204132,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Anagrelide.,20,Type_20,No
DB00599,Thiopental,DB00622,Nicardipine,0.39552393555641174,4,Type_4,The metabolism of Nicardipine can be increased when combined with Thiopental.,60,Type_60,No
DB00215,Citalopram,DB00680,Moricizine,0.454028457403183,73,Type_73,The serum concentration of Moricizine can be increased when it is combined with Citalopram.,49,Type_49,No
DB00321,Amitriptyline,DB00398,Sorafenib,0.3924501836299896,73,Type_73,The serum concentration of Sorafenib can be increased when it is combined with Amitriptyline.,47,Type_47,No
DB00091,Cyclosporine,DB01166,Cilostazol,0.4950261414051056,47,Type_47,The metabolism of Cilostazol can be decreased when combined with Cyclosporine.,73,Type_73,No
DB01211,Clarithromycin,DB06216,Asenapine,0.4687393009662628,73,Type_73,The serum concentration of Asenapine can be increased when it is combined with Clarithromycin.,47,Type_47,No
DB00252,Phenytoin,DB00850,Perphenazine,0.41637420654296875,4,Type_4,The metabolism of Perphenazine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB01017,Minocycline,DB01189,Desflurane,0.47771012783050537,16,Type_16,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Desflurane.,16,Type_16,Yes
DB00224,Indinavir,DB01167,Itraconazole,0.4796057641506195,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Indinavir.,73,Type_73,No
DB00363,Clozapine,DB00849,Methylphenobarbital,0.28825250267982483,60,Type_60,Clozapine may increase the hypotensive activities of Methylphenobarbital.,49,Type_49,No
DB00400,Griseofulvin,DB01418,Acenocoumarol,0.4004024863243103,75,Type_75,The serum concentration of Acenocoumarol can be decreased when it is combined with Griseofulvin.,75,Type_75,Yes
DB00607,Nafcillin,DB00977,Ethinylestradiol,0.4193236529827118,70,Type_70,The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Nafcillin.,4,Type_4,No
DB01149,Nefazodone,DB06605,Apixaban,0.4859018623828888,73,Type_73,The serum concentration of Apixaban can be increased when it is combined with Nefazodone.,73,Type_73,Yes
DB01072,Atazanavir,DB06772,Cabazitaxel,0.4670375883579254,73,Type_73,The serum concentration of Cabazitaxel can be increased when it is combined with Atazanavir.,73,Type_73,Yes
DB00254,Doxycycline,DB01098,Rosuvastatin,0.4931774437427521,47,Type_47,The metabolism of Rosuvastatin can be decreased when combined with Doxycycline.,47,Type_47,Yes
DB00898,Ethanol,DB01104,Sertraline,0.4535352885723114,49,Type_49,The risk or severity of adverse effects can be increased when Ethanol is combined with Sertraline.,49,Type_49,Yes
DB00647,Dextropropoxyphene,DB01246,Alimemazine,0.4738273024559021,60,Type_60,Dextropropoxyphene may increase the hypotensive activities of Alimemazine.,60,Type_60,Yes
DB00351,Megestrol acetate,DB01418,Acenocoumarol,0.4804513156414032,70,Type_70,The therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Megestrol acetate.,70,Type_70,Yes
DB00238,Nevirapine,DB00358,Mefloquine,0.46594321727752686,47,Type_47,The metabolism of Mefloquine can be decreased when combined with Nevirapine.,4,Type_4,No
DB00320,Dihydroergotamine,DB00669,Sumatriptan,0.49278169870376587,49,Type_49,The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Sumatriptan.,49,Type_49,Yes
DB01203,Nadolol,DB01580,Oxprenolol,0.4677235186100006,25,Type_25,Nadolol may increase the atrioventricular blocking (AV block) activities of Oxprenolol.,60,Type_60,No
DB00503,Ritonavir,DB04861,Nebivolol,0.4910019338130951,47,Type_47,The metabolism of Nebivolol can be decreased when combined with Ritonavir.,73,Type_73,No
DB00458,Imipramine,DB04861,Nebivolol,0.4632565677165985,73,Type_73,The serum concentration of Nebivolol can be increased when it is combined with Imipramine.,73,Type_73,Yes
DB00738,Pentamidine,DB01261,Sitagliptin,0.4186145067214966,70,Type_70,The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Pentamidine.,70,Type_70,Yes
DB00331,Metformin,DB00440,Trimethoprim,0.4679570198059082,73,Type_73,The serum concentration of Trimethoprim can be increased when it is combined with Metformin.,73,Type_73,Yes
DB01220,Rifaximin,DB01221,Ketamine,0.32572370767593384,4,Type_4,The metabolism of Ketamine can be increased when combined with Rifaximin.,73,Type_73,No
DB00752,Tranylcypromine,DB08931,Riociguat,0.4114735722541809,60,Type_60,Tranylcypromine may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB00537,Ciprofloxacin,DB01197,Captopril,0.41266247630119324,82,Type_82,Ciprofloxacin may increase the arrhythmogenic activities of Captopril.,82,Type_82,Yes
DB00215,Citalopram,DB05039,Indacaterol,0.45408105850219727,20,Type_20,Citalopram may increase the QTc-prolonging activities of Indacaterol.,20,Type_20,Yes
DB00849,Methylphenobarbital,DB01242,Clomipramine,0.4372602105140686,4,Type_4,The metabolism of Clomipramine can be increased when combined with Methylphenobarbital.,4,Type_4,Yes
DB00705,Delavirdine,DB04898,Ximelagatran,0.48338672518730164,47,Type_47,The metabolism of Ximelagatran can be decreased when combined with Delavirdine.,75,Type_75,No
DB01377,Magnesium oxide,DB04574,Estrone sulfate,0.3502271771430969,73,Type_73,The serum concentration of Estrone sulfate can be increased when it is combined with Magnesium oxide.,3,Type_3,No
DB00908,Quinidine,DB01192,Oxymorphone,0.48537033796310425,47,Type_47,The metabolism of Oxymorphone can be decreased when combined with Quinidine.,47,Type_47,Yes
DB00246,Ziprasidone,DB00933,Mesoridazine,0.49659624695777893,49,Type_49,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Mesoridazine.,47,Type_47,No
DB00295,Morphine,DB00755,Tretinoin,0.4687328040599823,49,Type_49,The risk or severity of adverse effects can be increased when Morphine is combined with Tretinoin.,49,Type_49,Yes
DB00285,Venlafaxine,DB09068,Vortioxetine,0.47928813099861145,47,Type_47,The metabolism of Vortioxetine can be decreased when combined with Venlafaxine.,49,Type_49,No
DB00599,Thiopental,DB08907,Canagliflozin,0.4198325276374817,60,Type_60,Thiopental may increase the hypotensive activities of Canagliflozin.,60,Type_60,Yes
DB01120,Gliclazide,DB05812,Abiraterone,0.37275272607803345,73,Type_73,The serum concentration of Abiraterone can be increased when it is combined with Gliclazide.,47,Type_47,No
DB00201,Caffeine,DB01132,Pioglitazone,0.47903385758399963,47,Type_47,The metabolism of Pioglitazone can be decreased when combined with Caffeine.,47,Type_47,Yes
DB00477,Chlorpromazine,DB04855,Dronedarone,0.4413437247276306,47,Type_47,The metabolism of Dronedarone can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB00751,Epinastine,DB01264,Darunavir,0.48053035140037537,47,Type_47,The metabolism of Darunavir can be decreased when combined with Epinastine.,73,Type_73,No
DB00796,Candesartan cilexetil,DB08880,Teriflunomide,0.46096479892730713,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Candesartan cilexetil.,49,Type_49,No
DB00863,Ranitidine,DB00884,Risedronic acid,0.44063833355903625,70,Type_70,The therapeutic efficacy of Risedronic acid can be decreased when used in combination with Ranitidine.,18,Type_18,No
DB01222,Budesonide,DB01232,Saquinavir,0.49350982904434204,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Budesonide.,73,Type_73,No
DB01095,Fluvastatin,DB04855,Dronedarone,0.48568323254585266,73,Type_73,The serum concentration of Dronedarone can be increased when it is combined with Fluvastatin.,47,Type_47,No
DB00458,Imipramine,DB01274,Arformoterol,0.485146164894104,20,Type_20,Imipramine may increase the QTc-prolonging activities of Arformoterol.,47,Type_47,No
DB00427,Triprolidine,DB01580,Oxprenolol,0.3207687735557556,49,Type_49,The risk or severity of adverse effects can be increased when Triprolidine is combined with Oxprenolol.,49,Type_49,Yes
DB00614,Furazolidone,DB06148,Mianserin,0.39263010025024414,2,Type_2,Furazolidone may increase the anticholinergic activities of Mianserin.,49,Type_49,No
DB04898,Ximelagatran,DB08873,Boceprevir,0.2925577163696289,75,Type_75,The serum concentration of Boceprevir can be decreased when it is combined with Ximelagatran.,75,Type_75,Yes
DB00238,Nevirapine,DB06594,Agomelatine,0.3377542197704315,4,Type_4,The metabolism of Agomelatine can be increased when combined with Nevirapine.,73,Type_73,No
DB00320,Dihydroergotamine,DB01219,Dantrolene,0.47292476892471313,47,Type_47,The metabolism of Dantrolene can be decreased when combined with Dihydroergotamine.,47,Type_47,Yes
DB01083,Orlistat,DB09119,Eslicarbazepine acetate,0.494873046875,75,Type_75,The serum concentration of Eslicarbazepine acetate can be decreased when it is combined with Orlistat.,75,Type_75,Yes
DB00697,Tizanidine,DB00822,Disulfiram,0.4217119514942169,73,Type_73,The serum concentration of Disulfiram can be increased when it is combined with Tizanidine.,73,Type_73,Yes
DB00947,Fulvestrant,DB09065,Cobicistat,0.4965629577636719,73,Type_73,The serum concentration of Cobicistat can be increased when it is combined with Fulvestrant.,47,Type_47,No
DB01418,Acenocoumarol,DB09323,Benzylpenicillin benzathine hydrate,0.49964427947998047,6,Type_6,Acenocoumarol may increase the anticoagulant activities of Benzylpenicillin benzathine hydrate.,6,Type_6,Yes
DB00451,Levothyroxine,DB04575,Quinestrol,0.2985643744468689,67,Type_67,Levothyroxine can cause a decrease in the absorption of Quinestrol resulting in a reduced serum concentration and potentially a decrease in efficacy.,70,Type_70,No
DB00285,Venlafaxine,DB01076,Atorvastatin,0.44598695635795593,49,Type_49,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Atorvastatin.,49,Type_49,Yes
DB00279,Liothyronine,DB06695,Dabigatran etexilate,0.44805195927619934,6,Type_6,Liothyronine may increase the anticoagulant activities of Dabigatran etexilate.,75,Type_75,No
DB00321,Amitriptyline,DB00715,Paroxetine,0.4662042558193207,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Paroxetine.,49,Type_49,Yes
DB00263,Sulfisoxazole,DB00344,Protriptyline,0.4903213679790497,47,Type_47,The metabolism of Protriptyline can be decreased when combined with Sulfisoxazole.,20,Type_20,No
DB00175,Pravastatin,DB00678,Losartan,0.44079530239105225,47,Type_47,The metabolism of Losartan can be decreased when combined with Pravastatin.,47,Type_47,Yes
DB01580,Oxprenolol,DB01588,Prazepam,0.4335366487503052,73,Type_73,The serum concentration of Prazepam can be increased when it is combined with Oxprenolol.,49,Type_49,No
DB00549,Zafirlukast,DB01076,Atorvastatin,0.4667145609855652,47,Type_47,The metabolism of Atorvastatin can be decreased when combined with Zafirlukast.,49,Type_49,No
DB00297,Bupivacaine,DB00477,Chlorpromazine,0.3556719422340393,4,Type_4,The metabolism of Chlorpromazine can be increased when combined with Bupivacaine.,47,Type_47,No
DB00252,Phenytoin,DB01264,Darunavir,0.4240761399269104,75,Type_75,The serum concentration of Darunavir can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB00875,Flupentixol,DB01211,Clarithromycin,0.37456393241882324,20,Type_20,Flupentixol may increase the QTc-prolonging activities of Clarithromycin.,20,Type_20,Yes
DB00420,Promazine,DB00637,Astemizole,0.4920383393764496,20,Type_20,Promazine may increase the QTc-prolonging activities of Astemizole.,47,Type_47,No
DB00489,Sotalol,DB01211,Clarithromycin,0.348854660987854,20,Type_20,Sotalol may increase the QTc-prolonging activities of Clarithromycin.,20,Type_20,Yes
DB00543,Amoxapine,DB06697,Artemether,0.455567866563797,20,Type_20,Amoxapine may increase the QTc-prolonging activities of Artemether.,20,Type_20,Yes
DB00472,Fluoxetine,DB00531,Cyclophosphamide,0.4608791470527649,47,Type_47,The metabolism of Cyclophosphamide can be decreased when combined with Fluoxetine.,47,Type_47,Yes
DB01275,Hydralazine,DB09216,Tolfenamic acid,0.45335444808006287,37,Type_37,Hydralazine may decrease the antihypertensive activities of Tolfenamic acid.,37,Type_37,Yes
DB00700,Eplerenone,DB01348,Spirapril,0.4469310939311981,68,Type_68,Eplerenone may increase the hyperkalemic activities of Spirapril.,68,Type_68,Yes
DB00637,Astemizole,DB01232,Saquinavir,0.44293248653411865,47,Type_47,The metabolism of Saquinavir can be decreased when combined with Astemizole.,73,Type_73,No
DB00361,Vinorelbine,DB00679,Thioridazine,0.44359904527664185,73,Type_73,The serum concentration of Thioridazine can be increased when it is combined with Vinorelbine.,73,Type_73,Yes
DB00283,Clemastine,DB09083,Ivabradine,0.4305001199245453,73,Type_73,The serum concentration of Ivabradine can be increased when it is combined with Clemastine.,73,Type_73,Yes
DB00246,Ziprasidone,DB00915,Amantadine,0.40746939182281494,20,Type_20,Ziprasidone may increase the QTc-prolonging activities of Amantadine.,20,Type_20,Yes
DB00951,Isoniazid,DB01195,Flecainide,0.4553627669811249,73,Type_73,The serum concentration of Flecainide can be increased when it is combined with Isoniazid.,47,Type_47,No
DB00220,Nelfinavir,DB00283,Clemastine,0.43291470408439636,73,Type_73,The serum concentration of Clemastine can be increased when it is combined with Nelfinavir.,47,Type_47,No
DB00699,Nicergoline,DB09118,Stiripentol,0.4544980227947235,49,Type_49,The risk or severity of adverse effects can be increased when Nicergoline is combined with Stiripentol.,47,Type_47,No
DB00381,Amlodipine,DB01098,Rosuvastatin,0.4923946261405945,47,Type_47,The metabolism of Rosuvastatin can be decreased when combined with Amlodipine.,73,Type_73,No
DB00361,Vinorelbine,DB00476,Duloxetine,0.38455620408058167,49,Type_49,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Duloxetine.,47,Type_47,No
DB00983,Formoterol,DB01264,Darunavir,0.4576191306114197,47,Type_47,The metabolism of Darunavir can be decreased when combined with Formoterol.,73,Type_73,No
DB00279,Liothyronine,DB00476,Duloxetine,0.4082369804382324,9,Type_9,Liothyronine may increase the hypoglycemic activities of Duloxetine.,70,Type_70,No
DB00531,Cyclophosphamide,DB08882,Linagliptin,0.45108526945114136,73,Type_73,The serum concentration of Linagliptin can be increased when it is combined with Cyclophosphamide.,49,Type_49,No
DB01037,Selegiline,DB01395,Drospirenone,0.3819330036640167,49,Type_49,The risk or severity of adverse effects can be increased when Selegiline is combined with Drospirenone.,73,Type_73,No
DB00238,Nevirapine,DB01195,Flecainide,0.42154166102409363,75,Type_75,The serum concentration of Flecainide can be decreased when it is combined with Nevirapine.,47,Type_47,No
DB00468,Quinine,DB01244,Bepridil,0.35966384410858154,20,Type_20,Quinine may increase the QTc-prolonging activities of Bepridil.,60,Type_60,No
DB00266,Dicoumarol,DB01022,Phylloquinone,0.4730337858200073,70,Type_70,The therapeutic efficacy of Phylloquinone can be decreased when used in combination with Dicoumarol.,12,Type_12,No
DB00715,Paroxetine,DB00960,Pindolol,0.3786318302154541,73,Type_73,The serum concentration of Pindolol can be increased when it is combined with Paroxetine.,47,Type_47,No
DB00519,Trandolapril,DB06414,Etravirine,0.36350733041763306,75,Type_75,The serum concentration of Etravirine can be decreased when it is combined with Trandolapril.,75,Type_75,Yes
DB00280,Disopyramide,DB08873,Boceprevir,0.4336363673210144,73,Type_73,The serum concentration of Boceprevir can be increased when it is combined with Disopyramide.,47,Type_47,No
DB00207,Azithromycin,DB01037,Selegiline,0.4344256520271301,47,Type_47,The metabolism of Selegiline can be decreased when combined with Azithromycin.,47,Type_47,Yes
DB00193,Tramadol,DB00285,Venlafaxine,0.36246493458747864,64,Type_64,Tramadol may increase the serotonergic activities of Venlafaxine.,27,Type_27,No
DB00363,Clozapine,DB06697,Artemether,0.41667887568473816,47,Type_47,The metabolism of Artemether can be decreased when combined with Clozapine.,47,Type_47,Yes
DB05294,Vandetanib,DB12332,Rucaparib,0.4081009328365326,47,Type_47,The metabolism of Rucaparib can be decreased when combined with Vandetanib.,47,Type_47,Yes
DB00850,Perphenazine,DB01264,Darunavir,0.4555118680000305,47,Type_47,The metabolism of Darunavir can be decreased when combined with Perphenazine.,73,Type_73,No
DB00321,Amitriptyline,DB01072,Atazanavir,0.47771310806274414,47,Type_47,The metabolism of Atazanavir can be decreased when combined with Amitriptyline.,47,Type_47,Yes
DB00248,Cabergoline,DB01016,Glyburide,0.49483826756477356,49,Type_49,The risk or severity of adverse effects can be increased when Cabergoline is combined with Glyburide.,49,Type_49,Yes
DB00367,Levonorgestrel,DB01072,Atazanavir,0.4401661455631256,75,Type_75,The serum concentration of Atazanavir can be decreased when it is combined with Levonorgestrel.,73,Type_73,No
DB00495,Zidovudine,DB05265,Ecabet,0.4539729654788971,47,Type_47,The metabolism of Ecabet can be decreased when combined with Zidovudine.,75,Type_75,No
DB00333,Methadone,DB01221,Ketamine,0.36612892150878906,16,Type_16,Methadone may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,49,Type_49,No
DB00420,Promazine,DB01167,Itraconazole,0.4763861894607544,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Promazine.,47,Type_47,Yes
DB08882,Linagliptin,DB09289,Tianeptine,0.4856811463832855,73,Type_73,The serum concentration of Tianeptine can be increased when it is combined with Linagliptin.,73,Type_73,Yes
DB00418,Secobarbital,DB01169,Arsenic trioxide,0.48095399141311646,49,Type_49,The risk or severity of adverse effects can be increased when Secobarbital is combined with Arsenic trioxide.,60,Type_60,No
DB00175,Pravastatin,DB00622,Nicardipine,0.35676106810569763,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Pravastatin.,47,Type_47,Yes
DB00598,Labetalol,DB01193,Acebutolol,0.4228212535381317,25,Type_25,Labetalol may increase the atrioventricular blocking (AV block) activities of Acebutolol.,30,Type_30,No
DB00987,Cytarabine,DB09280,Lumacaftor,0.4943767189979553,75,Type_75,The serum concentration of Lumacaftor can be decreased when it is combined with Cytarabine.,4,Type_4,No
DB00555,Lamotrigine,DB01035,Procainamide,0.4282199442386627,47,Type_47,The metabolism of Procainamide can be decreased when combined with Lamotrigine.,73,Type_73,No
DB00908,Quinidine,DB01157,Trimetrexate,0.44722771644592285,47,Type_47,The metabolism of Trimetrexate can be decreased when combined with Quinidine.,73,Type_73,No
DB00310,Chlorthalidone,DB00898,Ethanol,0.4098578095436096,73,Type_73,The serum concentration of Ethanol can be increased when it is combined with Chlorthalidone.,30,Type_30,No
DB01210,Levobunolol,DB01242,Clomipramine,0.45387041568756104,73,Type_73,The serum concentration of Clomipramine can be increased when it is combined with Levobunolol.,49,Type_49,No
DB00472,Fluoxetine,DB00489,Sotalol,0.342901349067688,20,Type_20,Fluoxetine may increase the QTc-prolonging activities of Sotalol.,73,Type_73,No
DB00795,Sulfasalazine,DB00817,Rosoxacin,0.4726966619491577,27,Type_27,Sulfasalazine may increase the neuroexcitatory activities of Rosoxacin.,27,Type_27,Yes
DB00753,Isoflurane,DB08881,Vemurafenib,0.35262975096702576,75,Type_75,The serum concentration of Vemurafenib can be decreased when it is combined with Isoflurane.,75,Type_75,Yes
DB00598,Labetalol,DB01611,Hydroxychloroquine,0.3955765664577484,73,Type_73,The serum concentration of Hydroxychloroquine can be increased when it is combined with Labetalol.,47,Type_47,No
DB00521,Carteolol,DB04846,Celiprolol,0.30004405975341797,49,Type_49,The risk or severity of adverse effects can be increased when Carteolol is combined with Celiprolol.,60,Type_60,No
DB01118,Amiodarone,DB01224,Quetiapine,0.489763081073761,47,Type_47,The metabolism of Quetiapine can be decreased when combined with Amiodarone.,73,Type_73,No
DB01241,Gemfibrozil,DB04908,Flibanserin,0.3715948164463043,73,Type_73,The serum concentration of Flibanserin can be increased when it is combined with Gemfibrozil.,73,Type_73,Yes
DB00238,Nevirapine,DB01259,Lapatinib,0.32931938767433167,4,Type_4,The metabolism of Lapatinib can be increased when combined with Nevirapine.,75,Type_75,No
DB01167,Itraconazole,DB01224,Quetiapine,0.4924188256263733,73,Type_73,The serum concentration of Quetiapine can be increased when it is combined with Itraconazole.,73,Type_73,Yes
DB00531,Cyclophosphamide,DB01098,Rosuvastatin,0.42997249960899353,49,Type_49,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Rosuvastatin.,73,Type_73,No
DB01069,Promethazine,DB06697,Artemether,0.38638678193092346,47,Type_47,The metabolism of Artemether can be decreased when combined with Promethazine.,20,Type_20,No
DB01403,Methotrimeprazine,DB01409,Tiotropium,0.36285606026649475,2,Type_2,Methotrimeprazine may increase the anticholinergic activities of Tiotropium.,47,Type_47,No
DB00238,Nevirapine,DB04846,Celiprolol,0.4088134467601776,47,Type_47,The metabolism of Celiprolol can be decreased when combined with Nevirapine.,4,Type_4,No
DB00603,Medroxyprogesterone acetate,DB09075,Edoxaban,0.3296032249927521,75,Type_75,The serum concentration of Edoxaban can be decreased when it is combined with Medroxyprogesterone acetate.,70,Type_70,No
DB06707,Levonordefrin,DB09244,Pirlindole,0.4677301347255707,71,Type_71,Levonordefrin may increase the hypertensive activities of Pirlindole.,71,Type_71,Yes
DB00960,Pindolol,DB01087,Primaquine,0.4634748697280884,47,Type_47,The metabolism of Primaquine can be decreased when combined with Pindolol.,47,Type_47,Yes
DB00656,Trazodone,DB01167,Itraconazole,0.3668556809425354,47,Type_47,The metabolism of Itraconazole can be decreased when combined with Trazodone.,47,Type_47,Yes
DB00477,Chlorpromazine,DB08873,Boceprevir,0.48882219195365906,47,Type_47,The metabolism of Boceprevir can be decreased when combined with Chlorpromazine.,47,Type_47,Yes
DB06770,Benzyl alcohol,DB08880,Teriflunomide,0.3303385078907013,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Benzyl alcohol.,75,Type_75,Yes
DB01233,Metoclopramide,DB01601,Lopinavir,0.44864100217819214,47,Type_47,The metabolism of Lopinavir can be decreased when combined with Metoclopramide.,20,Type_20,No
DB01045,Rifampicin,DB08932,Macitentan,0.4968271255493164,75,Type_75,The serum concentration of Macitentan can be decreased when it is combined with Rifampicin.,75,Type_75,Yes
DB00906,Tiagabine,DB06148,Mianserin,0.44044074416160583,49,Type_49,The risk or severity of adverse effects can be increased when Tiagabine is combined with Mianserin.,70,Type_70,No
DB00384,Triamterene,DB00872,Conivaptan,0.4581947922706604,73,Type_73,The serum concentration of Conivaptan can be increased when it is combined with Triamterene.,49,Type_49,No
DB00363,Clozapine,DB00373,Timolol,0.44169899821281433,47,Type_47,The metabolism of Timolol can be decreased when combined with Clozapine.,47,Type_47,Yes
DB00182,Amphetamine,DB00514,Dextromethorphan,0.41051119565963745,49,Type_49,The risk or severity of adverse effects can be increased when Amphetamine is combined with Dextromethorphan.,64,Type_64,No
DB01390,Sodium bicarbonate,DB01577,Metamfetamine,0.3733574151992798,72,Type_72,Sodium bicarbonate may decrease the excretion rate of Metamfetamine which could result in a higher serum level.,72,Type_72,Yes
DB00615,Rifabutin,DB06228,Rivaroxaban,0.3602861762046814,4,Type_4,The metabolism of Rivaroxaban can be increased when combined with Rifabutin.,75,Type_75,No
DB01211,Clarithromycin,DB09236,Lacidipine,0.48120108246803284,47,Type_47,The metabolism of Lacidipine can be decreased when combined with Clarithromycin.,47,Type_47,Yes
DB00653,Magnesium sulfate,DB00738,Pentamidine,0.3408929407596588,75,Type_75,The serum concentration of Pentamidine can be decreased when it is combined with Magnesium sulfate.,49,Type_49,No
DB00454,Meperidine,DB04876,Vildagliptin,0.4611264765262604,49,Type_49,The risk or severity of adverse effects can be increased when Meperidine is combined with Vildagliptin.,49,Type_49,Yes
DB01355,Hexobarbital,DB04574,Estrone sulfate,0.33284229040145874,75,Type_75,The serum concentration of Estrone sulfate can be decreased when it is combined with Hexobarbital.,70,Type_70,No
DB01242,Clomipramine,DB08882,Linagliptin,0.33895617723464966,73,Type_73,The serum concentration of Linagliptin can be increased when it is combined with Clomipramine.,73,Type_73,Yes
DB01015,Sulfamethoxazole,DB01418,Acenocoumarol,0.4221456050872803,6,Type_6,Sulfamethoxazole may increase the anticoagulant activities of Acenocoumarol.,6,Type_6,Yes
DB01154,Thiamylal,DB01220,Rifaximin,0.49674004316329956,73,Type_73,The serum concentration of Rifaximin can be increased when it is combined with Thiamylal.,4,Type_4,No
DB00440,Trimethoprim,DB01197,Captopril,0.4758511185646057,68,Type_68,Trimethoprim may increase the hyperkalemic activities of Captopril.,68,Type_68,Yes
DB01395,Drospirenone,DB12598,Nafamostat,0.3530716001987457,73,Type_73,The serum concentration of Nafamostat can be increased when it is combined with Drospirenone.,68,Type_68,No
DB00477,Chlorpromazine,DB09274,Artesunate,0.39287006855010986,73,Type_73,The serum concentration of Artesunate can be increased when it is combined with Chlorpromazine.,73,Type_73,Yes
DB06717,Fosaprepitant,DB08906,Fluticasone furoate,0.3753518760204315,4,Type_4,The metabolism of Fluticasone furoate can be increased when combined with Fosaprepitant.,73,Type_73,No
DB00297,Bupivacaine,DB00363,Clozapine,0.3398738205432892,47,Type_47,The metabolism of Clozapine can be decreased when combined with Bupivacaine.,47,Type_47,Yes
DB00604,Cisapride,DB01110,Miconazole,0.4459843933582306,47,Type_47,The metabolism of Miconazole can be decreased when combined with Cisapride.,73,Type_73,No
DB00252,Phenytoin,DB00283,Clemastine,0.307015597820282,73,Type_73,The serum concentration of Clemastine can be increased when it is combined with Phenytoin.,47,Type_47,No
DB00374,Treprostinil,DB01097,Leflunomide,0.4555668234825134,47,Type_47,The metabolism of Leflunomide can be decreased when combined with Treprostinil.,49,Type_49,No
DB01403,Methotrimeprazine,DB01601,Lopinavir,0.44982537627220154,73,Type_73,The serum concentration of Lopinavir can be increased when it is combined with Methotrimeprazine.,20,Type_20,No
DB00363,Clozapine,DB00476,Duloxetine,0.42012280225753784,49,Type_49,The risk or severity of adverse effects can be increased when Clozapine is combined with Duloxetine.,73,Type_73,No
DB00870,Suprofen,DB01240,Epoprostenol,0.47048407793045044,49,Type_49,The risk or severity of adverse effects can be increased when Suprofen is combined with Epoprostenol.,70,Type_70,No
DB01377,Magnesium oxide,DB01576,Dextroamphetamine,0.47418850660324097,75,Type_75,The serum concentration of Dextroamphetamine can be decreased when it is combined with Magnesium oxide.,72,Type_72,No
DB00289,Atomoxetine,DB00531,Cyclophosphamide,0.45594504475593567,15,Type_15,Atomoxetine may increase the cardiotoxic activities of Cyclophosphamide.,47,Type_47,No
DB00091,Cyclosporine,DB01406,Danazol,0.4943027198314667,80,Type_80,Cyclosporine may increase the hepatotoxic activities of Danazol.,80,Type_80,Yes
DB00358,Mefloquine,DB01175,Escitalopram,0.3325616419315338,9,Type_9,Mefloquine may increase the hypoglycemic activities of Escitalopram.,20,Type_20,No
DB00679,Thioridazine,DB06708,Lumefantrine,0.28785955905914307,73,Type_73,The serum concentration of Lumefantrine can be increased when it is combined with Thioridazine.,73,Type_73,Yes
DB01608,Periciazine,DB06697,Artemether,0.4997798502445221,33,Type_33,The risk or severity of QTc prolongation can be increased when Periciazine is combined with Artemether.,73,Type_73,No
DB00779,Nalidixic acid,DB01223,Aminophylline,0.31815311312675476,70,Type_70,The therapeutic efficacy of Aminophylline can be decreased when used in combination with Nalidixic acid.,47,Type_47,No
DB00907,Cocaine,DB01166,Cilostazol,0.4663945138454437,47,Type_47,The metabolism of Cilostazol can be decreased when combined with Cocaine.,47,Type_47,Yes
DB01261,Sitagliptin,DB01348,Spirapril,0.4008106291294098,73,Type_73,The serum concentration of Spirapril can be increased when it is combined with Sitagliptin.,49,Type_49,No
DB00238,Nevirapine,DB00762,Irinotecan,0.40001165866851807,47,Type_47,The metabolism of Irinotecan can be decreased when combined with Nevirapine.,75,Type_75,No
DB00227,Lovastatin,DB06335,Saxagliptin,0.45113056898117065,47,Type_47,The metabolism of Saxagliptin can be decreased when combined with Lovastatin.,73,Type_73,No
DB00820,Tadalafil,DB01029,Irbesartan,0.48305368423461914,10,Type_10,Tadalafil may increase the antihypertensive activities of Irbesartan.,10,Type_10,Yes
DB00738,Pentamidine,DB01016,Glyburide,0.4035312235355377,9,Type_9,Pentamidine may increase the hypoglycemic activities of Glyburide.,9,Type_9,Yes
DB00682,Warfarin,DB01026,Ketoconazole,0.4404442012310028,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Warfarin.,73,Type_73,No
DB00679,Thioridazine,DB08909,Glycerol phenylbutyrate,0.3847324252128601,73,Type_73,The serum concentration of Glycerol phenylbutyrate can be increased when it is combined with Thioridazine.,73,Type_73,Yes
DB00091,Cyclosporine,DB01229,Paclitaxel,0.49306735396385193,49,Type_49,The risk or severity of adverse effects can be increased when Cyclosporine is combined with Paclitaxel.,47,Type_47,No
DB00740,Riluzole,DB06210,Eltrombopag,0.3908575773239136,47,Type_47,The metabolism of Eltrombopag can be decreased when combined with Riluzole.,73,Type_73,No
DB01054,Nitrendipine,DB01355,Hexobarbital,0.45373356342315674,4,Type_4,The metabolism of Hexobarbital can be increased when combined with Nitrendipine.,4,Type_4,Yes
DB00297,Bupivacaine,DB00458,Imipramine,0.44915732741355896,49,Type_49,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Imipramine.,47,Type_47,No
DB01016,Glyburide,DB01580,Oxprenolol,0.4620914161205292,9,Type_9,Glyburide may increase the hypoglycemic activities of Oxprenolol.,9,Type_9,Yes
DB01377,Magnesium oxide,DB01427,Amrinone,0.4086911380290985,70,Type_70,The therapeutic efficacy of Amrinone can be decreased when used in combination with Magnesium oxide.,49,Type_49,No
DB00373,Timolol,DB00476,Duloxetine,0.38531896471977234,30,Type_30,Timolol may increase the orthostatic hypotensive activities of Duloxetine.,30,Type_30,Yes
DB00622,Nicardipine,DB00889,Granisetron,0.4983082711696625,20,Type_20,Nicardipine may increase the QTc-prolonging activities of Granisetron.,20,Type_20,Yes
DB00641,Simvastatin,DB01054,Nitrendipine,0.3849368989467621,73,Type_73,The serum concentration of Nitrendipine can be increased when it is combined with Simvastatin.,73,Type_73,Yes
DB00722,Lisinopril,DB01211,Clarithromycin,0.49069783091545105,73,Type_73,The serum concentration of Clarithromycin can be increased when it is combined with Lisinopril.,70,Type_70,No
DB01064,Isoprenaline,DB04861,Nebivolol,0.47751563787460327,5,Type_5,Isoprenaline may decrease the vasoconstricting activities of Nebivolol.,14,Type_14,No
DB00252,Phenytoin,DB06216,Asenapine,0.4710121154785156,4,Type_4,The metabolism of Asenapine can be increased when combined with Phenytoin.,4,Type_4,Yes
DB00498,Phenindione,DB01022,Phylloquinone,0.4450676739215851,12,Type_12,Phenindione may decrease the anticoagulant activities of Phylloquinone.,12,Type_12,Yes
DB00502,Haloperidol,DB00622,Nicardipine,0.4691125154495239,47,Type_47,The metabolism of Nicardipine can be decreased when combined with Haloperidol.,47,Type_47,Yes
DB00313,Valproic acid,DB00458,Imipramine,0.37521877884864807,49,Type_49,The risk or severity of adverse effects can be increased when Valproic acid is combined with Imipramine.,73,Type_73,No
DB00924,Cyclobenzaprine,DB04839,Cyproterone acetate,0.4982227385044098,73,Type_73,The serum concentration of Cyproterone acetate can be increased when it is combined with Cyclobenzaprine.,75,Type_75,No
DB00252,Phenytoin,DB08860,Pitavastatin,0.4003336727619171,75,Type_75,The serum concentration of Pitavastatin can be decreased when it is combined with Phenytoin.,75,Type_75,Yes
DB00582,Voriconazole,DB01026,Ketoconazole,0.42639583349227905,47,Type_47,The metabolism of Ketoconazole can be decreased when combined with Voriconazole.,47,Type_47,Yes
DB00932,Tipranavir,DB01071,Mequitazine,0.3068780303001404,73,Type_73,The serum concentration of Mequitazine can be increased when it is combined with Tipranavir.,73,Type_73,Yes
DB01166,Cilostazol,DB01236,Sevoflurane,0.24486543238162994,49,Type_49,The risk or severity of adverse effects can be increased when Cilostazol is combined with Sevoflurane.,6,Type_6,No
DB00502,Haloperidol,DB13783,Acemetacin,0.4226461350917816,70,Type_70,The therapeutic efficacy of Acemetacin can be decreased when used in combination with Haloperidol.,49,Type_49,No
DB00436,Bendroflumethiazide,DB01193,Acebutolol,0.28024205565452576,49,Type_49,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Acebutolol.,49,Type_49,Yes
DB00296,Ropivacaine,DB01029,Irbesartan,0.42598026990890503,47,Type_47,The metabolism of Irbesartan can be decreased when combined with Ropivacaine.,49,Type_49,No
DB00615,Rifabutin,DB06148,Mianserin,0.38138487935066223,75,Type_75,The serum concentration of Mianserin can be decreased when it is combined with Rifabutin.,4,Type_4,No
DB00799,Tazarotene,DB08880,Teriflunomide,0.41513654589653015,75,Type_75,The serum concentration of Teriflunomide can be decreased when it is combined with Tazarotene.,47,Type_47,No
DB00207,Azithromycin,DB00266,Dicoumarol,0.4687022566795349,73,Type_73,The serum concentration of Dicoumarol can be increased when it is combined with Azithromycin.,73,Type_73,Yes
DB00315,Zolmitriptan,DB08880,Teriflunomide,0.40802034735679626,73,Type_73,The serum concentration of Teriflunomide can be increased when it is combined with Zolmitriptan.,75,Type_75,No
DB00898,Ethanol,DB01289,Glisoxepide,0.40096157789230347,49,Type_49,The risk or severity of adverse effects can be increased when Ethanol is combined with Glisoxepide.,49,Type_49,Yes
DB00474,Methohexital,DB08931,Riociguat,0.46333715319633484,60,Type_60,Methohexital may increase the hypotensive activities of Riociguat.,60,Type_60,Yes
DB00531,Cyclophosphamide,DB00619,Imatinib,0.47798484563827515,15,Type_15,Cyclophosphamide may increase the cardiotoxic activities of Imatinib.,15,Type_15,Yes
DB01101,Capecitabine,DB01320,Fosphenytoin,0.34993013739585876,4,Type_4,The metabolism of Fosphenytoin can be increased when combined with Capecitabine.,73,Type_73,No
DB00883,Isosorbide dinitrate,DB01167,Itraconazole,0.49466976523399353,73,Type_73,The serum concentration of Itraconazole can be increased when it is combined with Isosorbide dinitrate.,47,Type_47,No
DB00367,Levonorgestrel,DB01045,Rifampicin,0.3863532543182373,4,Type_4,The metabolism of Rifampicin can be increased when combined with Levonorgestrel.,4,Type_4,Yes
DB00321,Amitriptyline,DB12598,Nafamostat,0.3783129155635834,49,Type_49,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Nafamostat.,73,Type_73,No
DB00361,Vinorelbine,DB01403,Methotrimeprazine,0.4763495922088623,47,Type_47,The metabolism of Methotrimeprazine can be decreased when combined with Vinorelbine.,47,Type_47,Yes
DB01138,Sulfinpyrazone,DB01238,Aripiprazole,0.49019601941108704,75,Type_75,The serum concentration of Aripiprazole can be decreased when it is combined with Sulfinpyrazone.,75,Type_75,Yes
DB09065,Cobicistat,DB09123,Dienogest,0.4046618342399597,73,Type_73,The serum concentration of Dienogest can be increased when it is combined with Cobicistat.,73,Type_73,Yes
DB00542,Benazepril,DB00696,Ergotamine,0.49585193395614624,73,Type_73,The serum concentration of Ergotamine can be increased when it is combined with Benazepril.,73,Type_73,Yes
DB00555,Lamotrigine,DB01026,Ketoconazole,0.29072311520576477,49,Type_49,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Ketoconazole.,49,Type_49,Yes
DB01166,Cilostazol,DB08816,Ticagrelor,0.37835779786109924,53,Type_53,Cilostazol may increase the antiplatelet activities of Ticagrelor.,6,Type_6,No
DB00401,Nisoldipine,DB00857,Terbinafine,0.4906209707260132,47,Type_47,The metabolism of Terbinafine can be decreased when combined with Nisoldipine.,49,Type_49,No
DB00420,Promazine,DB01015,Sulfamethoxazole,0.4753420948982239,20,Type_20,Promazine may increase the QTc-prolonging activities of Sulfamethoxazole.,20,Type_20,Yes
DB00594,Amiloride,DB00864,Tacrolimus,0.4052554965019226,68,Type_68,Amiloride may increase the hyperkalemic activities of Tacrolimus.,42,Type_42,No
